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Regulation of translation directly controls gene expression levels from mRNA
to protein in the translation cycle steps. Ribosome arrest peptides (RAPs) are often
conditional modulators interacting with the ribosomal tunnel and induce transla-
tional stalling to regulate downstream gene expression in cis to fulfill real-time cel-
lular needs. The ribosomal tunnel also provides a protected environment for initial
protein folding. This dissertation’s first publication presents a 2.9 Å cryo-electron
microscopy structure of a ribosome stalled during translation of the extremely com-
pacted VemP nascent chain. The nascent chain forms two α-helices connected by an
α-turn and a loop, enabling a total of 37 amino acids to be observed within the first
50–55 Å of the ribosomal tunnel.
The structure reveals how α-helix formation directly within the peptidyltrans-
ferase center (PTC) of the ribosome interferes with aminoacyl-tRNA (A-tRNA) ac-
commodation, suggesting that for canonical translation, a significant role of the ri-
bosomal tunnel is to prevent excessive secondary structure formation that can in-
terfere with the peptidyltransferase activity of the ribosome. On the other hand,
secondary structure formation at the PTC could also be used by the ribosome for
specific nascent proteins like RAPs to modulate the rate of translation, which could
have significant downstream consequences for co-translational protein targeting
and folding.
Relief of VemP-mediated ribosome stalling is proposed to result from the translo-
con pulling force exerted on VemP nascent chain’s N-terminal signal sequence. For
VemP, force application would inevitably prevent the formation of the extensive
secondary structure during translation or lead to an unraveling of any secondary
structure that does form within the tunnel, thereby eventually allowing the steri-
cal transition into the induced conformation of the PTC. This work obtained novel
insights into the underlying mechanisms of RAP-mediated ribosome force sensing.
viii
A translating ribosome can also be stalled on the mRNA owing to defective
translational components such as non-stop/no-go mRNAs. To maintain ribosome
and protein homeostasis, the ribosome-associated quality control (RQC) system has
evolved to rescue the stalled ribosome and release the incomplete nascent protein
for degradation through disassembling the translation machinery in eukaryotic cells.
After dissociation of ribosomes, the stalled tRNA-bound peptide remains associ-
ated with the 60S subunit and extended by Rqc2 by adding C-terminal alanyl and
threonyl residues (CAT tails), whereas Vms1 catalyzes cleavage and release of the
peptidyl-tRNA before or after addition of CAT tails. In doing so, Vms1 counteracts
CAT-tailing of nuclear-encoded mitochondrial proteins that otherwise drive aggre-
gation and compromise mitochondrial and cellular homeostasis.
This dissertation’s second publication presents structural and functional insights
into the interaction of Saccharomyces cerevisiae Vms1 with 60S subunits in pre- and
post-peptidyl-tRNA cleavage states. Vms1 binds to 60S subunits with its Vms1-like
release factor 1 (VLRF1), zinc finger, and ankyrin domains. VLRF1 overlaps with
the Rqc2 A-tRNA position and interacts with the ribosomal A-site, projecting its cat-
alytic GSQ motif towards the CCA end of the tRNA, its Y285 residue dislodging the
tRNA base 73 for nucleolytic cleavage. Moreover, in the pre-state, ABCF-type AT-
Pase Arb1 was found in the ribosomal E-site, which stabilizes the delocalized base 73
of the peptidyl-tRNA and stimulates Vms1-dependent tRNA cleavage. These struc-
tural analyses provided mechanistic insights into the interplay of the RQC factors
Vms1, Rqc2, and Arb1 and their role in protecting mitochondria from the aggrega-
tion of toxic proteins.
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Proteins are macromolecules consisting of long chains of amino acid residues. They
are involved in every biological process within organisms, including providing struc-
ture to cells, catalyzing reactions, and communicating chemical signals.
1.1 Translation and Ribosome
Translation is the process of biological protein synthesis from the genetic informa-
tion of a messenger RNA (mRNA) template. An mRNA is a sequence of nucleotide
triplets known as codons, determining when translation should start and terminate,
as well as the order of amino acids to be added to the nascent polypeptide. Ri-
bosomes are the macromolecular machines to decode mRNA information into the
polypeptide chain by catalyzing peptide bonds between amino acids.
Ribosomes are comprised of ribosomal RNA (rRNA) and ribosomal proteins (r-
proteins), and each ribosome consists of a small and a large subunit. The small sub-
unit contains the mRNA tunnel and the decoding center to assign codon matching
transfer RNAs (tRNAs) charged with particular amino acids. The large subunit pos-
sesses the peptidyl-transferase center (PTC) that forms peptide bonds, and harbors
the ribosomal tunnel elongating from PTC to the solvent side of the subunit for the
nascent polypeptide chain to pass through. The space between the small and large
subunits comprises three tRNA binding sites, namely aminoacyl, peptidyl, and exit
sites (A-, P-, and E-sites).
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The core features and functions of ribosomes are conserved through kingdoms
of lives. However, through evolution, ribosomes layered more rRNA and r-proteins
upon the core architecture and therefore became larger. The molecular weight of an
Escherichia coli (E. coli) ribosome is 2.3 MDa, while it is 3.3 MDa for yeast. Based on
the sedimentation coefficient in Svedberg units (S), bacterial cells contain 70S formed
by the small subunit 30S and the large subunit 50S, whereas eukaryotic cells have
80S formed by the small subunit 40S and large subunit 60S (Wilson and Cate, 2012;
Melnikov et al., 2012). Eukaryotic ribosomes contain extra rRNAs expanding like
"tentacles," known as expansion segments (ES). In particular, ES27 in Saccharomyces
cerevisiae has been shown to adopt in two distinct conformations and can interact
with factors binding to the exit of the ribosomal tunnel (Beckmann et al., 2001; Knorr
et al., 2019).
1.2 Translation cycle
Translation of mRNA to polypeptides by the ribosome is a highly coordinated cy-
cle, which can be divided into four steps: initiation, elongation, termination, and
recycling.
1.2.1 Initiation
Despite broad conservation of the core mechanisms for translational machinery through
kingdoms of lives, translation initiation is distinct in prokaryotes and eukaryotes
due to the distinct cell partition. In prokaryotes, as no nucleus to segregate the tran-
scription and translation, ribosomes can initiate co-transcriptionally, i.e., as long as
the start sites in an mRNA are available (Gualerzi and Pon, 2015; Buskirk and Green,
2017). By contrast, eukaryotic ribosomes only engage with completed mRNAs pos-
sessing a cap and a poly-A tail. In bacteria, three initiation factors (IFs), IF1, IF2, and
IF3, together with the Shine Dalgarno (SD) sequence locating upstream of the start
codon (Shine and Dalgarno, 1974), establish base-pair interactions with the anti-SD
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sequence on the 16S rRNA to accommodate the start codon in the P-site (Kaminishi
et al., 2007; Korostelev et al., 2007). On the other hand, eukaryotes form a 43S preini-
tiation complex to bind the cap feature at the 5’-end of eukaryotic mRNA and scan
from 5’ to 3’ until reaching the start codon. The preinitiation complex consists of
at least twelve IFs, the small subunit, and the initiator tRNA (Met-tRNAi) (Jackson,
Hellen, and Pestova, 2010). When the start codon is in place, the large subunit joins,
and elongation starts upon release of IFs (Jackson, Hellen, and Pestova, 2010).
1.2.2 Elongation
During elongation, the ribosome translates the mRNA continuously from 5’ to 3’
with elongation factors (EFs). EF-Tu in bacteria or its homolog, eukaryotic EF1
(eEF1), delivers aminoacyl-tRNAs (aa-tRNA) to the A-site (Noble and Song, 2008;
Agirrezabala and Frank, 2009; Dever and Green, 2012). When a cognate tRNA is
bound to the mRNA codon at the A-site, EF-Tu/eEF1 hydrolyses guanosine triphos-
phate (GTP) to dissociate from the aa-tRNA, allowing the tRNA to accommodate at
the A-site. Next, the ribosome transfers the nascent chain to the aa-tRNA by form-
ing a peptide bond at the PTC. Subsequently, EF-G in bacteria or eEF2 in eukaryotes
binds to the ribosome and translocates the mRNA by one codon, causing the current
P-site deacylated tRNA to move to the E-site and the A-site peptidyl-tRNA to the P-
site (Dever and Green, 2012). This translocation is a dynamic process (Blanchard et
al., 2004): a. the tRNAs move with respect to the large subunit resulting in A/P and
P/E hybrid states (the first letter indicates the respective position of the tRNA on the
small subunit and the latter indicates the large subunit); b. this hybrid states is cou-
pled to the rotation of the ribosome subunits relative to one another, and EF-G/eEF2
preferentially binds to the rotated ribosome (Frank and Agrawal, 2000; Dever and
Green, 2012). After EF-G/eEF2 hydrolyses GTP and leaves the ribosome, the A-site
is vacant again for the next aa-tRNA to bind (Noller et al., 2002). This elongation
cycle is repeated until a stop codon is reached to terminate the translation.
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1.2.3 Termination
When the signal of translation termination, a stop codon, reaches the A-site, it is
recognized by a class-I release factor (RF) instead of any tRNA to release the nascent
chain from the ribosome (Korostelev et al., 2008; Weixlbaumer et al., 2008; Dever and
Green, 2012; Preis et al., 2014; Brown et al., 2015; Matheisl et al., 2015). Although the
three standard stop codons, UAA, UAG, and UGA, are universal through kingdoms
of lives, bacteria and eukaryotes possess structurally unrelated class-I RFs. Bacterial
RF1 is responsible for recognizing UAA and UAG, and RF2 recognizes UAA and
UGA, whereas eukaryotic RF1 (eRF1) can recognize all three stop codons. Stud-
ies have shown that eRF1 recognizes a quadruplet codon, contributing to forming
a UNR-type U-tern for the N-terminus of eRF1 to recognize (Matheisl et al., 2015;
Brown et al., 2015). Despite the structural distinction, RF1/RF2 and eRF1 all display
a universally conserved GGQ motif that precisely positions one water molecule at
the PTC, hydrolyzing the peptidyl-tRNA ester bond by a nucleophilic attack, and
thus releasing the nascent chain from the ribosome (Song et al., 2000; Kisselev,
Ehrenberg, and Frolova, 2003; Korostelev, 2011). Apart from class-I RFs, various
class-II RFs are also needed to assist termination. Bacterial RF3 releases RF1/RF2
from the ribosome (Zavialov et al., 2002), while eukaryotic RF2 (eRF2) delivers eRF1
to the ribosome and promotes its activity (Preis et al., 2014; Shao and Hegde, 2016).
1.2.4 Recycling
After the release of NC, the ribosome needs to be recycled into subunits for the
next round of translation. In bacteria, the ribosome recycling factor (RRF) and
EF-G split the post-termination complex, a ribosome bound to the mRNA and a
deacetylated tRNA in the P-site, into the 50S and a 30S-tRNA-mRNA complex, fol-
lowed by IF3 disassociating the tRNA and mRNA off the 30S (Zavialov et al., 2002;
Peske, Rodnina, and Wintermeyer, 2005). In eukaryotes, however, termination is
coupled with ribosome recycling through the combined action of the splitting factor
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ABCE1 and eRF1 (Pisarev, Hellen, and Pestova, 2007; Becker et al., 2012; Franck-
enberg, Becker, and Beckmann, 2012). ABCE1 is an adenosine triphosphate (ATP)-
binding cassette sub-family E (ABCE)-type ATPase with two nucleotide-binding do-
mains (NBDs) linked by a domain containing a conserved iron-sulfur cluster (FeS)
(Karcher, Schele, and Hopfner, 2008). Upon binding to the termination complex,
ribosome bound to the mRNA, a peptidyl-tRNA in the P-site, and eRF1 in the A-
site, ABCE1 hydrolyzes ATP to close the NBDs for pushing the FeS domain into the
inter-subunit cleft, thereby splitting the 80S (Becker et al., 2012; Preis et al., 2014;
Heuer et al., 2017).
1.3 Ribosome arrest peptides (RAPs)
1.3.1 Cis-regulatory elements of translation
Regulation of translation directly controls gene expression levels from mRNA to
protein in the translation cycle steps. Increasing number of RAPs often encoded
in upstream open reading frames (uORF) or mRNA 5’ leaders have been identified
to be modulators interfering with ribosomes to adjust their downstream gene ex-
pression in cis throughout kingdoms of lives (Lovett and Rogers, 1996; Wilson and
Beckmann, 2011; Cruz-Vera et al., 2011; Ito and Chiba, 2013; Wethmar, 2014; Wilson,
Arenz, and Beckmann, 2016)
An elongating RAP passing through the ribosomal tunnel conditionally or natu-
rally interacts with critical components in the tunnel to induce the ribosome stalling
on the RAP mRNA. A stalling ribosome’s position on the mRNA is usually precise
to the codon level, thereby accurately triggering a consequence affecting the transla-
tion of the following gene (Ito and Chiba, 2013). In bacteria, a RAP-stalled ribosome
typically upregulates the downstream gene expression. One classic approach to
achieve this is that such stalled ribosome, by its physical presence, alters the mRNA
secondary structure, thereby exposing the downstream gene’s SD sequence to other
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free ribosomes (Ito and Chiba, 2013). When the stalling is relieved upon changing
conditions, the canonical translation cycle ensues, i.e., ribosomes rapidly leave the
mRNA after translating the RAP, leading to the fast refolding of the mRNA, and thus
repressing the following gene’s expression due to the mostly hidden SD sequence
(Ito and Chiba, 2013).
From the perspective of the conditions to induce/release ribosome stalling, RAPs,
together with the ribosomes, can be seen to work as sensors responding to distinct
cues. According to the cue types, RAPs can be divided into:
1. small molecule sensors, such as the tryptophan sensor TnaC (Seidelt et al.,
2009; Gong and Yanofsky, 2001; Gong and Yanofsky, 2002; Bischoff, Berninghausen,
and Beckmann, 2014; Wilson, Arenz, and Beckmann, 2016) and the antibiotic sen-
sors (Ramu, Mankin, and Vazquez-Laslop, 2009), ErmBL (Shivakumar et al., 1980;
Horinouchi and Weisblum, 1980; Arenz et al., 2016) and ErmCL (Vazquez-Laslop,
Thum, and Mankin, 2008; Arenz et al., 2014; Johansson et al., 2014; Wilson, Arenz,
and Beckmann, 2016);
2. mechanical force sensors, SecM (Nakatogawa and Ito, 2001; Nakatogawa and
Ito, 2002; Gao et al., 2015), MifM (Chiba, Lamsa, and Pogliano, 2009; Chiba et al.,
2011; Sohmen et al., 2015; Wilson, Arenz, and Beckmann, 2016), and the recently
identified VemP (Ishii et al., 2015);
3. and no relieving non-sensors like the viral RAP hCMV (Degnin et al., 1993;
Bhushan et al., 2010; Matheisl et al., 2015; Wilson, Arenz, and Beckmann, 2016).
The force sensors SecM and VemP are both destined to be exported by Sec-
mediated protein secretion (SecA for SecM and SecDF for VemP). When the membrane-
associated Sec machinery applies a pulling force to their nascent polypeptide chain,
the translation operates canonically. However, when there is a lack of force, they
stall the ribosome to allow their downstream motor gene (SecA for SecM and SecDF2
for VemP) to be expressed (McNicholas, Salavati, and Oliver, 1997; Ishii et al., 2015)
and resume the translation upon sensing the presence of force again (Butkus, Prun-
deanu, and Oliver, 2003; Gumbart et al., 2012; Ismail et al., 2012). Similarly, MifM
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is destined to be integrated into the membrane by the membrane protein insertase
YidC1 or YidC2, and induces YidC2 expression when sensing the absence of force
(Chiba et al., 2011).
More RAP sequences are being discovered in nature may indicate that cis-regulation
of translation is commonly utilized by cells to respond to changes in the intracellu-
lar or extracellular environment. Along those lines, the ribosomal tunnel is proven
not to be a passive conduit for a nascent chain to pass through but provides a frame-
work to modulate the translation rate directly and rapidly, especially compared to
the transcriptional regulation.
The ribosomal tunnel is approximately 100 Angstroms (Å) in length and 10 to 20
Å in diameter; starting from the PTC, it constricts around the middle region (con-
striction site) and becomes broad at the tunnel exit (vestibule). At the PTC, criti-
cal bases such as U2585 and U2506 (E. coli numbering) are often stabilized in the
uninduced state by RAPs upon stalling (Ito and Chiba, 2013; Wilson, Arenz, and
Beckmann, 2016). In the interior, the tunnel’s surface consists mainly of rRNA, but
residues from uL4 and uL22 also contribute as key discriminators at the constric-
tion site (Ito and Chiba, 2013; Wilson, Arenz, and Beckmann, 2016). Although the
inner surface is largely hydrophilic and uncharged, RAPs can usually form critical
interactions to strengthen the stalling, mainly between the PTC and the constriction
site. Notably, MifM stalls ribosomes in Bacillus subtilis (B. subtilis) but not in E. coli,
demonstrating a species-sensitive regulatory mechanism fine-tuned by one single
amino acid within uL22 (Sohmen et al., 2015). Apart from the vestibule possess-
ing space for small domains to fold, the rest of the ribosomal tunnel, especially the
constriction site, has been considered not allowing folds larger than helices to form
(Voss et al., 2006).
VemP (Vibrio export monitoring polypeptide) is one of the most recently dis-
covered force-sensing arrest peptides allowing Vibrio alginolyticus (V. alginolyticus)
to adapt to salinity changes by modulating the expression of SecDF2, the compo-
nents of the Sec machinery (Ishii et al., 2015). V. alginolyticus has two paralogs
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of SecDF (SecDF1 and SecDF2) to enhance protein export in cooperation with the
SecYEG translocon. In Na+-rich environments, V. alginolyticus utilizes the Na+-
dependent SecDF1, whereas, in Na+-limiting environments, it switches to the Na+-
independent SecDF2. The VemP stalling activity facilitates this switch. In Na+-
rich environments, VemP is targeted by its signal sequence to the SecDF1-SecYEG
translocon. The force applied to VemP during translocation prevents VemP-dependent
ribosome stalling, and under such conditions, the expression of SecDF2 is repressed.
In Na+-limiting environments, however, the inactive SecDF1-SecYEG translocon
cannot translocate VemP. The absence of force on the VemP nascent chain then leads
to ribosome stalling and induces the expression of Na+-independent SecDF2 (Ishii
et al., 2015).
In comparing the identified amino acid residues contributing to the ribosome
stalling, VemP has the largest counts for crucial residues: 17 amino acid residues,
versus, for instance, nine for E. coli SecM, five for Mannheimia succiniciproducens
SecM, and ten for B. subtilis MifM (Ishii et al., 2015). However, the mechanisms
of how VemP senses force and why needing the longest RAP stretch is unknown.
1.3.2 Aim of the Publication 1
In this thesis, the aim was to use cryo-electron microscopy to solve the structure of
the VemP-stalled ribosome complex at the atomic level to gain novel insights into
the underlying mechanisms of RAP-mediated ribosome force sensing.
1.4 Ribosome-associated protein quality control (RQC)
1.4.1 Saving cells from aberrant stalling of translation
A translating ribosome can be stalled on the mRNA owing to defective transla-
tional components such as non-stop/no-go mRNAs (Brandman and Hegde, 2016;
Joazeiro, 2015). To maintain ribosome and protein homeostasis, mRNA surveillance
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and RQC systems have evolved to degrade the faulty mRNA, rescue the stalled ri-
bosome and release the incomplete nascent protein for degradation.
Recent work showed that recognizing such an aberrant stall due is initiated by
ribosome collision, which initiates quality control pathways. In yeast, stalled ribo-
somes can be dissociated into 60S and 40S subunits by Hbs1 (Hbs1L and Gtpbp2
in mammals) and Dom34 (Pelota in mammals) in concert with the ABC-ATPase
ABCE1 (Shoemaker, Eyler, and Green, 2010; Pisareva et al., 2011; Becker et al.,
2012; Tsuboi et al., 2012). After splitting, the peptidyl-tRNA remains associated
with the 60S subunit to which the RQC components Rqc1, Ltn1, Rqc2 (Tae2), and
Cdc48 bind. Ltn1 (Listerin) is an E3 ligase and ubiquitylates the faulty polypeptides
as they emerge from the ribosomal tunnel exit (Bengtson and Joazeiro, 2010). The
AAA-ATPase Cdc48 functions in extracting the stalled polypeptides from the ribo-
some and delivers them to the ubiquitin-proteasome system (UPS) for degradation
(Verma et al., 2013). Rqc1 is involved in ubiquitylation and delivery to the UPS,
and Rqc2 stabilizes Ltn1 on the 60S subunit (Brandman et al., 2012; Defenouillère
et al., 2013; Lyumkis et al., 2014; Shao et al., 2015; Shen et al., 2015). The primary
function of Rqc2, however, is its ability to elongate the nascent peptide chains on the
60S subunit by the addition of alanyl and threonyl residues of the stalled polypep-
tide chains, so-called CAT tails, by an mRNA independent mechanism (Shen et al.,
2015). The role of Rqc2 is only incompletely understood, particularly the process
of elongating the peptidyl chain. One function of this elongation is to expose ly-
sine residues at the ribosomal tunnel exit to enable their ubiquitylation and thereby
facilitate UPS-mediated degradation (Kostova et al., 2017).
Notably, CAT-tails’ presence can cause aggregation of the released peptides and
other proteins in the cytosol and mitochondria (Choe et al., 2016; Defenouillère et
al., 2016; Yonashiro et al., 2016; Izawa et al., 2017). In contrast to cytosolic pro-
teins, however, clearance of stalled nuclear-encoded mitochondrial proteins is con-
founded by the fact that their transport across the mitochondrial membranes can
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proceed co-translationally, which occurs preferentially when the translation is re-
tarded or stalled. Consequently, ribosomes accumulate at the mitochondrial surface,
and the stalled mitochondrial polypeptides tend to be protected from ubiquitylation
by Ltn1, thereby escaping proteasomal degradation. This favors CAT-tailing of these
proteins by Rqc2, which, once imported, form highly toxic aggregates within the mi-
tochondria: Co-aggregation and sequestration of critical mitochondrial chaperones
results in defective assembly of respiratory chain complexes and mitochondrial dys-
function (Izawa et al., 2017).
The protein Vms1 (valosin-containing protein/Cdc48-associated mitochondrial
stress-responsive 1) was shown to have a protective role in mitochondrial homeosta-
sis. Vms1 was originally described as a cytosolic protein that interacts with Cdc48
and associates with mitochondria upon oxidative stress and the endoplasmic retic-
ulum (Heo et al., 2010; Tran, Tomsic, and Brodsky, 2011; Nielson et al., 2017). Its
deletion was observed to cause respiratory dysfunction when yeast cells reach the
stationary phase and impair cells’ growth defective in exosome-mediated mRNA
degradation. More recently, Vms1 was reported to bind to 60S subunits at the mi-
tochondrial surface and antagonize Rqc2 binding to 60S ribosomes (Izawa et al.,
2017). Vms1 may reduce the efficiency of Rqc2 activity by increasing the speed of
protein import into the mitochondria. This requires a rapid release of the stalled
polypeptide from the 60S subunit through hydrolysis of the peptidyl-tRNA.
Indeed, Vms1 was recently reported to stimulate the cleavage of peptidyl-tRNA
(Verma et al., 2018; Rendón et al., 2018; Kuroha et al., 2018). However, the molecular
mechanisms by which Vms1 antagonizes Rqc2 acts as tRNA hydrolase or nuclease
and rescues mitochondrial homeostasis are only poorly understood.
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1.4.2 Aim of the Publication 2
In this thesis, the goal was to analyze the interaction of Vms1 with 60S subunits
and study its function using combined cryo-electron microscopy, genetic, and bio-
chemical approaches with yeast as a model system. This structural study aimed at
gaining mechanistic insights into the interplay of the RQC factors and their role in
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Abstract Interaction between the nascent polypeptide chain and the ribosomal exit tunnel can
modulate the rate of translation and induce translational arrest to regulate expression of
downstream genes. The ribosomal tunnel also provides a protected environment for initial protein
folding events. Here, we present a 2.9 Å cryo-electron microscopy structure of a ribosome stalled
during translation of the extremely compacted VemP nascent chain. The nascent chain forms two a-
helices connected by an a-turn and a loop, enabling a total of 37 amino acids to be observed within
the first 50–55 Å of the exit tunnel. The structure reveals how a-helix formation directly within the
peptidyltransferase center of the ribosome interferes with aminoacyl-tRNA accommodation,
suggesting that during canonical translation, a major role of the exit tunnel is to prevent excessive




Many diverse nascent chain sequences have been identified that act as cis-regulatory polypeptides
to promote ribosome stalling and thereby regulate gene expression. One of the most recently dis-
covered examples is the Vibrio export monitoring polypeptide (VemP) that allows Vibrio alginolyticus
to adapt to changes in salinity by modulating expression of components of the protein targeting
machinery (Ishii et al., 2015). V. alginolyticus is a Gram-negative marine-estuarine bacterium that,
unlike most bacteria, has two paralogs of SecDF (SecDF1 and SecDF2) to enhance protein export in
cooperation with the SecYEG translocon. In Na+-rich environments, V. alginolyticus utilizes the Na+-
dependent SecDF1; however, in Na+-limiting environments V. alginolyticus switches to the Na+-inde-
pendent (presumably H+-dependent) SecDF2 (Ishii et al., 2015). The switch between SecDF1 and
SecDF2 is facilitated by the stalling activity of VemP. In Na+-rich environments, VemP is targeted by
its signal sequence (SS) to the SecDF1-SecYEG translocon (Ishii et al., 2015). The force applied to
VemP during protein translocation prevents VemP-dependent ribosome stalling, thereby enabling
the complete VemP to be translated and released from the ribosome. Under such conditions,
SecDF2 expression is repressed due to sequestration of the ribosome-binding site (RBS) of secDF2
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within a stem-loop structure in the mRNA (Figure 1a). In Na+-limiting environments, however, VemP
is not translocated due to the inactivity of SecDF1, and the resulting lack of force on the VemP
nascent chain leads to ribosomal stalling (Figure 1a). Ribosome stalling dissolves the stem-loop
structure within the mRNA, exposes the RBS and thereby induces expression of Na+-independent
SecDF2 (Figure 1a). In brief, the mechanisms by which VemP switches protein synthesis between the
SecDF1 and SecDF2 paralogs is dependent on the application of a force to the signal sequence con-
taining VemP nascent chain. This force serves as a direct indicator of the SecDF-SecYEG protein
translocation activity, which in turn is dependent on the environmental conditions.
Biochemical studies have demonstrated that VemP-dependent stalling occurs when Q156 is in
the P-site of the ribosome and that distinct amino acid residues within a 19aa window (138–156) of
VemP are critical for efficient ribosome stalling (Figure 1a) (Ishii et al., 2015). Although VemP-
Figure 1. Biochemical and structural analysis of VemP stalling. (a) Schematic representation of the VemP-SecDF2 mRNA encoding VemP leader peptide
with N-terminal signal sequence (SS) and C-terminal stalling region (green), followed by a stem-loop structure that sequesters the ribosome-binding
site (RBS) of the SecDF2 gene (left). The translation arrest of VemP maintains the unfolded conformation of the mRNA allowing ribosome binding and
induction of SecDF2 expression. The VemP stalling window H138–Q156 (boxed) is shown with critical (green bold) and important (green) residues
highlighted (Ishii et al., 2015), and an asterisk indicating the stop codon (right). (b–c) In vivo pulse-chase analysis with different VemP constructs; VemP
‘short’ (H138–Q156, orange), VemP ‘long’ (F131–Q156, pink), VemP ‘GS’ (purple) and VemP mutants L153A and Q156*. (d) Schematic of the VemP-SRC
used for cryo-EM. (e–f) Western blot against the N-terminal HA-tag of in vitro translated DSS-VemP detecting stalled peptidyl-tRNA (I), stalled free
peptide (II) or full-length free peptide (III), (e) in the absence and presence of RNase A treatment, or (f) as a function of time (25, 40, 55, 70, 85, 100 min).
(g) Transverse section of cryo-EM structure of the VemP-SRC showing the peptidyl-tRNA (green), with small and large subunits coloured in yellow and
blue, respectively.
DOI: 10.7554/eLife.25642.002
The following figure supplements are available for figure 1:
Figure supplement 1. Triplicates of the pulse-chase analysis.
DOI: 10.7554/eLife.25642.003
Figure supplement 2. Classification of the VemP-SRC.
DOI: 10.7554/eLife.25642.004
Figure supplement 3. Resolution of the VemP-SRC.
DOI: 10.7554/eLife.25642.005
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mediated regulation of SecDF2 expression is reminiscent of other peptide-stalling regulatory sys-
tems (Ito and Chiba, 2013; Wilson et al., 2016), such as SecM (Nakatogawa and Ito, 2001) and
MifM (Chiba et al., 2009), the VemP stalling sequence and force-sensing mechanism appears to be
completely distinct (Ishii et al., 2015; Ito and Chiba, 2013).
Results
Analysis of VemP sequence on efficiency of stalling
To ensure the stalling efficiency of the VemP constructs before initiating the structural analysis, we
engineered three LepB-based constructs carrying C-terminal VemP residues, termed VemP ‘short’,
‘long’ and ‘GS’, respectively (Figure 1b,c). VemP ‘short’ carries the 19 amino acid segment that Ishii
et al had chosen as the target for alanine scanning mutagenesis from VemP (138–156) (Ishii et al.,
2015). VemP ‘long’ carries a 26 amino acid long segment including seven additional N-terminal resi-
dues of VemP (131–156), whereas VemP ‘GS’ is similar to the former two, except that residues 131–
138 were substituted with a glycine-serine (GS) linker (Figure 1b,c). VemP ‘short’, ‘long’ and ‘GS’
were expressed in pulse-chase experiments in E. coli without any N-terminal signal sequence (see
Material and methods). Using this assay, the major product observed to accumulate for VemP ‘short’
was full-length LepB-VemP fusion protein, whereas relatively little (10%) stalled peptide was
detected (Figure 1b,c and Figure 1—figure supplement 1). In contrast, VemP ‘long’ containing the
extended stalling window dramatically increased the stalling efficiency (Figure 1b,c). As expected,
mutations previously reported to abrogate ribosome stalling (Ishii et al., 2015), L153A and
Q156stop, led to a reduction in stalling efficiency for the VemP ‘short’ and particularly for the VemP
‘long’ constructs. VemP ‘GS’ also had a reduced stalling efficiency (Figure 1b,c). Taken together,
these fusion proteins proved to be ineffective at inducing elongation arrest to the full extent in vivo.
The influence of residues 131–138 on ribosome stalling and SecDF2 induction was not so extensively
characterized in the previous study, where only mutation of residues 132 and 136–138 to alanine
were reported to have little or no effect (Ishii et al., 2015). Thus, our results suggest that residues
beyond the previously characterized 19-aa stalling window of VemP contribute to the efficiency of
VemP-mediated translation arrest.
Cryo-EM structure of the VemP-SRC
In order to investigate which residues of VemP are involved in establishing interactions with the exit
tunnel during ribosome stalling, and in particular to decipher the molecular mechanism of force-sen-
sitive ribosome stalling by VemP, we used cryo-EM to determine the structure of a VemP-stalled
ribosome-nascent chain complex (VemP-SRC). Since we observed a contribution of the amino acids
in VemP beyond the initially identified stalling window and to ensure the maximum ribosome stalling
efficiency, the wildtype VemP sequence lacking only the signal sequence (residues 26–159, DSS-
VemP), rather than a shorter stalling window, was used (Figure 1d). Translation of the DSS-VemP
construct in an E. coli lysate-based translation system led to the accumulation of VemP-peptidyl-
tRNA (about 40 kDa), of which the size was reduced to the expected free peptide (18 kDa) upon
RNase treatment (Figure 1e). The robustness of stalling of the wildtype DSS-VemP was evident from
the persistence of the VemP-peptidyl-tRNA, even with incubation times of up to 100 min where only
minor fractions of full-length VemP were produced (Figure 1f). The VemP-SRC was purified using
sucrose density gradient centrifugation and N-terminal affinity tags and subjected to cryo-EM analy-
sis (see Materials and methods). In silico sorting of the VemP-SRC dataset yielded a major subpopu-
lation of ribosomal particles that contained stoichiometric occupancy of the P-tRNA (Figure 1—
figure supplement 2). Subsequent refinement resulted in a final reconstruction of the VemP-SRC
(Figure 1g) with an average resolution of 2.9 Å and a local resolution of 2.5 Å within the core of the
ribosome (Figure 1—figure supplement 3 and Table 1). The electron density for the majority of the
VemP nascent chain was well resolved within the exit tunnel, with local resolution ranging between
3.0 and 3.5 Å (Figure 1—figure supplement 3), thus enabling a molecular model for residues 120–
156 of VemP to be built de novo (Figure 2 and Videos 1 and 2).
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Extreme compaction of the VemP nascent chain in the ribosomal tunnel
The VemP nascent chain adopts an extremely compacted conformation within the exit tunnel com-
prising two a-helices, located in the upper and lower regions of the tunnel, connected by an a-turn
and loop (Figure 2a–d and Video 1). The a-helix located in the upper region of the tunnel is com-
prised of the C-terminal 10 residues (N147–Q156) of VemP and is directly linked to the P-tRNA and
thereby located directly in the peptidyltransferase center (PTC) of the ribosome (Figure 2a,b). The
a-helix located in the lower region of the tunnel is comprised of the N-terminal 10 residues (M120–
S129) of VemP for which density is clearly visualized. We note that the N-terminal stretch of the
VemP nascent chain from the lower a-helix to tunnel exit is less well resolved (Figure 1—figure sup-
plement 3). The formation of a-helical secondary structure within the upper and lower regions of
the exit tunnel is generally consistent with previous biochemical and structural studies
(Bhushan et al., 2010a; Kosolapov and Deutsch, 2009; Lu and Deutsch, 2005; Matheisl et al.,
2015; Woolhead et al., 2004). The linker between the two a-helices is located within the constric-
tion of the exit tunnel, adjacent to ribosomal proteins uL4 and uL22 (Figure 2a–d). The linker is com-
posed of 17 residues (130–146) that form two consecutive turns: one connecting the C-terminal a-
helix which is a canonical a-turn (I140–K144), followed by a less well-ordered turn without hydrogen
bonding (Figure 2a–d and Video 2). Protein folding events have been demonstrated to occur within
the ribosomal exit tunnel (Holtkamp et al., 2015; Lin et al., 2012; Marino et al., 2016;
Nilsson et al., 2015; Tu et al., 2014); (Bhushan et al., 2010b; Matheisl et al., 2015); Of those so
far characterized, folding was shown to occur within the lower region of the tunnel, e.g. ADR1
(Nilsson et al., 2015) and within the vestibule at the periphery where the exit tunnel widens
(Cabrita et al., 2016; Nilsson et al., 2017; Trovato and O’Brien, 2016; Tu et al., 2014).
Table 1. Refinement and Model Statistics.
Data collection
Particles 400,024
Pixel size (Å) 1.084
Defocus range (mm) 1–2.5
Voltage (kV) 300





Resolution (Å, 0.143 FSC) 2.93





Rotamers outliers (%) 1.45
Ramachandran outliers (%) 1.00
Ramachandran favoured (%) 90.29
Correct sugar puckers (%) 98.77
Good backbone conformations (%) 81.74
Scores
MolProbity 1.96
Clash score, all atoms 5.45
DOI: 10.7554/eLife.25642.007
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Additionally, in the hCMV stalling peptide a
C-terminal a-helix was also observed in the
upper region of the tunnel in a similar yet slightly
shifted position compared to the C-terminal
helix of VemP (Figure 3) (Bhushan et al., 2010b;
Matheisl et al., 2015). Structurally, the extensive
compaction and secondary structure formation
of VemP results in an unprecedented total of 37
residues being housed within the upper two
thirds (approximately 50–55 Å) of the ribosomal
exit tunnel, which contrasts with the 21–33 aa
that were visualized within the exit tunnel for
other stalling peptides, such as SecM
(Bhushan et al., 2011; Zhang et al., 2015),
MifM (Sohmen et al., 2015), TnaC
(Bischoff et al., 2014; Seidelt et al., 2009) and
CMV (Bhushan et al., 2010b; Matheisl et al.,
2015) (Figure 3). When calculating the theoreti-
cal minimal number of residues for the VemP
peptide chain to stretch all the way from the
PTC to the tunnel exit, it would require at least
Figure 2. Overview of the VemP nascent chain in the ribosomal tunnel. (a–b) Isolated electron density and molecular model for the VemP nascent chain
connected to the P-tRNA (green) in the ribosomal tunnel (grey) with ribosomal proteins uL4 (cyan) and uL22 (orange) highlighted. (b) is the same as (a)
but rotated by 180˚. (c) Model of the VemP nascent chain in the ribosomal tunnel highlighting ribosomal components that interact with VemP, namely,
nucleotides of the 23S rRNA (blue) and ribosomal proteins uL4 (cyan) and uL22 (orange). (d) Rainbow representation of the VemP nascent chain with
sequence coloured accordingly. The upper and lower a-helices of VemP are boxed and the a-turn in the linking loop region is bracketed. Secondary
structure predictions for VemP are indicated with H (helix) and E (loop region).
DOI: 10.7554/eLife.25642.006
Video 1. Cryo-EM density and model for the VemP
nascent chain. Video showing the quality of the cryo-
EM density (green mesh) and fit of the molecular
model (green ribbon) of the VemP nascent chain and
CCA-end of the P-tRNA.
DOI: 10.7554/eLife.25642.008
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51 aa, which is in stark contrast to only 31 aa for MifM and 34 for SecM due to lack of compaction.
Interaction of VemP within the ribosomal exit tunnel
Alanine scanning mutagenesis of VemP identified 10 residues that are critical for ribosome stalling,
as well as an additional seven residues that significantly reduced stalling when mutated (Ishii et al.,
2015). These residues encompass 17 of the 19-aa stalling window of VemP ‘Short’, with only the
mutations of either S141A and S155A having no influence on ribosome stalling. Many of these resi-
dues establish specific interactions with components of the ribosomal exit tunnel, which is likely to
explain their importance for ribosomal stalling (Figure 4a–f). For example, the sidechains of N154
and Y150, which are located in the upper C-terminal a-helix of VemP, can stack on the nucleobases
of U2506 (Figure 4a) and C2610 (Figure 4c), respectively, of the 23S rRNA. Additionally, N154
comes within hydrogen bonding distance of U2584 (Figure 4b). Within the a-turn of VemP, K144
can hydrogen bond with the non-bridging phosphate-oxygen of U747 (Figure 4d), whereas W143
can stack upon the R92 sidechain located the tip of the b-hairpin of uL22 (Figure 4e). Consistently,
alterations in uL22 have been shown to reduce the efficiency of VemP-mediated ribosome stalling
(Ishii et al., 2015). The a-turn of VemP is additionally stabilized by stacking interactions between
R139 of VemP and A752 of the 23S rRNA (Figure 4f). The seven residues (131–137) within the loop
linking the a-turn of VemP to the lower N-terminal a-helix map within the VemP ‘Long’ region. As
mentioned, alanine mutagenesis (Y132A, S136–H138A) suggested that the identity of some of these
residues is not important for ribosome stalling, with the exception of the H138A mutation that had a
modest effect on arrest efficiency (Ishii et al., 2015). Consistently, in the VemP-SRC structure, resi-
dues 135–138 of loop are less well-resolved and no sidechain interactions with the exit tunnel are
observed. By contrast, the remaining loop residues (130–134) are better resolved. The sidechain of
H133 comes within hydrogen bonding distance of the backbone of K58 of uL4 (Figure 4g), which
may contribute to the improved stalling efficiency of the VemP ‘Long’ over the VemP ‘Short’
observed in Figure 1b. Additionally, the sidechain of W124, which is located in the lower N-terminal
a-helix of VemP, stacks on the R95 sidechain of uL22 (Figure 4h). Collectively, the interactions
observed in the VemP-SRC structure are consistent with previous biochemical and mutational analy-
sis indicating that the majority of critical residues and interactions are located in the upper region of
the tunnel, but that the additional residues within the lower region of the tunnel can also contribute
to the efficiency of stalling.
Silencing of the PTC by the C-terminal a-helix of VemP
Biochemical analysis indicates that VemP-stalled ribosomes arrest translation because peptide bond
formation cannot occur between Gln156 of the VemP-peptidyl-tRNA in the P-site and Phe157 of the
incoming aminoacyl-tRNA of the A-site (Ishii et al., 2015). Comparison of the conformation of
nucleotides at the PTC of the VemP-stalled ribosomes revealed two nucleotides of the 23S rRNA,
U2585 and U2506, which adopt conformations incompatible with peptide bond formation
(Figure 5a). Accommodation of an aminoacyl-tRNA at the A-site of the PTC requires a transition of
the PTC from an uninduced to an induced state, which involves a shift in the position of U2585
(Figure 5b) (Schmeing et al., 2005; Youngman et al., 2004). In the VemP-SRC, U2585 adopts a
unique conformation, distinct from both the uninduced and induced U2585 conformations
(Figure 5b). Moreover, the upper a-helix of VemP extends into the PTC and thereby directly pre-
vents the transition of U2585 from the uninduced to the induced state, due to steric clashes with
Asn154 of VemP (Figure 5c). In contrast to VemP, the hCMV helix does not directly prevent the anal-
ogous human nucleotide U4493 (E. coli U2585) from adopting the induced state. It is rather hCMV’s
penultimate Pro21, which is not part of the helix, that prevents this transition (Figure 5d). Addition-
ally, U2506 is observed to adopt two distinct conformations, U2506(a) and U2506(b) in the VemP-
SRC (Figure 5a). The U2506(a) conformation would sterically clash with the aminoacyl moiety of
A-tRNA (Figure 5e) and is likely to contribute to prevent aminoacyl-tRNA accommodation at the
A-site of the PTC. The induced state of the PTC also involves a shift in the position of U2506
(Schmeing et al., 2005; Youngman et al., 2004) (Figure 5f), which cannot occur in the VemP-SRC
because the upper a-helix of VemP blocks the induced conformation of U2506 (Figure 5g), analo-
gously to that observed for U2585 (Figure 5c). Unlike VemP, hCMV does not retain an uninduced
conformation of human U4414 (E. coli U2506) but allows the induced conformation of U4414 since it
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is sterically less constrained by the more distant
hCMV helix (Figure 5h) (Matheisl et al., 2015).
Taken together, although a-helix formation has
also been observed in the upper tunnel of an
hCMV-stalled ribosome (Matheisl et al., 2015),
the CMV a-helix did not directly extend into the
PTC as seen here for VemP (Figure 3f–g and
Figure 5d,h). Indeed, the two C-terminal proline
residues of the CMV stalling peptide appeared to
be more important for inactivating the PTC and
inducing translation arrest (Matheisl et al.,
2015). Notably, translation arrest via stabilization
of the uninduced state has also been observed
for other force-sensing stalling peptides on the
ribosome, such as SecM (Zhang et al., 2015) and
MifM (Sohmen et al., 2015). However, the mech-
anism is different since both, SecM and MifM,
adopt entirely extended conformations within the
tunnel, unlike VemP (Figure 3).
Discussion
Collectively, the VemP-SRC structure reveals that
VemP adopts an extremely compacted conforma-
tion within the ribosomal exit tunnel, comprising
an upper and a lower a-helix connected by an a-
turn and a loop. On the stalled ribosome, the upper a-helix of VemP encroaches directly upon the
PTC and stabilizes an uninduced state of the PTC that prevents accommodation of the incoming
A-tRNA and thereby promotes translation arrest (Figure 6a). These findings suggest that formation
of secondary structure, such as an a-helix, directly at the PTC is likely to be detrimental for peptide
bond formation and, therefore, for translation efficiency. Thus, the PTC of the ribosome and its
immediate tunnel context must have evolved to generally disfavour excessive secondary structure
formation. However, it also raises the question as to whether secondary structure formation at the
PTC is used by the ribosome for specific nascent proteins to modulate the rate of translation, which
could have important downstream consequences for co-translational protein folding and targeting
events.
Relief of VemP-mediated ribosome stalling is proposed to result from the force exerted on the
nascent chain during membrane insertion of the N-terminal signal sequence (Ishii et al., 2015). It is
easy to imagine how, in the case of VemP, force application would inevitably prevent the formation
of extensive secondary structure formation during translation, or at least lead to an unraveling of any
secondary structure that does form within the tunnel, and thereby eventually allowing sterically the
transition into the induced conformation of the PTC. As a result, peptide bond formation would be
promoted again and translation elongation continued (Figure 6b). Interestingly, all three molecularly
characterized force-sensing stallers employ the mechanism of preventing the adoption of the catalyt-
ically required induced state of the PTC by steric hindrance. This may be the favoured mechanism
because the conformational trajectory from the uninduced to the induced state coincides with the
direction of force applied to the nascent peptide (Figure 6b). Yet, it is surprising that the stalling
peptides use completely different modes by which they interact with the ribosomal tunnel in a force-
sensitive manner to achieve this goal.
Materials and methods
DNA manipulations
To test the effect of adding the extra C-terminal VemP sequence to the identified 19aa stalling win-
dow (Ishii et al., 2015), the VemP ‘short’ plasmid was constructed from a previously designed
Video 2. Cryo-EM density and model for a-turn and
loop of the VemP nascent chain. Video showing a
zoom of the cryo-EM density (green mesh) and fit of
the molecular model (stick representation) of the a-turn
and loop of the VemP nascent chain.
DOI: 10.7554/eLife.25642.009
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Figure 3. Comparison of the VemP nascent chain in the ribosomal tunnel with other stalling peptides. (a) Overall superposition of VemP (model in
green, surface in light green) with MifM (red, PDB ID 3J9W) (Sohmen et al., 2015), SecM (orange, PDB ID 3JBU) (Zhang et al., 2015), hCMV (yellow,
PDB ID 5A8L) (Matheisl et al., 2015), TnaC (cyan, PDB ID 4UY8) (Bischoff et al., 2014) and ErmBL (blue, PDB ID 5JU8)(Arenz et al., 2016) in the
ribosomal tunnel (light grey). The CCA-end of the P-tRNA is shown for reference. The ribosomal tunnel is shown schematically in grey. (b–f)
Superposition of VemP (green) with each arrest peptide described above. For (d) TnaC and (e) ErmBL, the two tryptophans (cyan) and the one
Figure 3 continued on next page
Su et al. eLife 2017;6:e25642. DOI: 10.7554/eLife.25642 8 of 17
Research article Biochemistry Biophysics and Structural Biology
pING1 plasmid carrying a lepB-based construct harboring a SecM arrest peptide (Ismail et al.,
2012). In order to produce a soluble, non-membrane targeted variant, transmembrane helix 1 and 2
of Lep were deleted using PCR. To replace the SecM arrest peptide with the VemP arrest sequence,
the plasmid was amplified using a primer pair producing a linear plasmid lacking the SecM arrest
peptide. Gibson assembly (Gibson et al., 2009) was then used to ligate synthesized oligonucleoti-
des corresponding to the VemP arrest peptide (in bold) and its following three residues, HRISGWKE
TNAMYVALNSQFSA, into the plasmid. Overlap PCR (Liu and Naismith, 2008) was used to replace
the seven Lep residues just upstream of the VemP ‘short’ arrest peptide with the corresponding
seven residues from the native VemP and by GSGSGSG to generate VemP ‘long’, FYHFTSDHRISG
WKETNAMYVALNSQFSA, and VemP ‘GS’, GSGSGSGHRISGWKETNAMYVALNSQFSA, respectively.
Overlap PCR was also used to generate other variants of VemP used in pulse-labelling analysis.
For in vitro translation and cryo-grid sample preparation, the full VemP gene without the signal
sequence (DSS-VemP, A26-A159) was cloned from synthesized V. alginolyticus genome by KOD
XtremeTM Hot-Start DNA Polymerase (Novagen, MA, USA), and subsequently inserted to modified
plasmid p7XNH3 by FX cloning method (Geertsma, 2014). The complete construct contains an
N-terminal His-tag for purification, a FLAG-tag for detection and a TEV-protease cleavage site as a
linker sequence. The C-terminus following the DSS-VemP comprises a spacer containing a 3C-prote-
ase cleavage site and an HA-tag.
MPWIYLRKLILLLFAMVLLPVHVSAAQIDHKAHVPHFSKLQPFVAVSVSPNSSVDFSEASEESSQSPVSE-
GHASLDSVALFNSQRWTSYLREGLDDEHVDFVGDLTTPFYADAGYAYSLMDINWRHNQSTFYHFTSDHRI
SGWKETNAMYVALNSQFSA(TAA-Stop x2) is the total amino acid sequence of the construct.
In vivo pulse-labelling
E. coli MC1061 carrying plasmids with the different lepB-based constructs described in the paper
were cultured overnight at 37˚C in M9 minimal medium supplemented with 19 natural amino acids
(1 mg/ml; no methionine, 100 mg/ml thiamine, 0.1 mM CaCl2, 2 mM MgSO4, 0.4% (w/v) fructose, and
100 mg/ml ampicillin). Overnight cultures were back-diluted to OD600 ~0.05–0.1 and grown 2.5 to
3.5 hr to an OD600 of 0.2–0.35. Protein expression was induced with 0.2% (w/v) arabinose for 5 min,
whereafter expressed proteins were radiolabelled with [35S]methionine for 2 min at 37˚C. Ice-cold tri-
chloroacetic acid (TCA) was added to a final concentration of 10% and the samples were incubated
on ice for 30 min. The samples were centrifuged for 5 min at 20,800 x g at 4˚C and the precipitates
were washed with cold acetone, and spun again for 5 min at 20,800 x g at 4˚C. The precipitates
were resolubilized in Tris-SDS solution (10 mM Tris-HCl, pH 7.5, and 2% SDS) at 95˚C for 10 min and
spun for 5 min at room temperature. The protein of interest was then immunoprecipitated using
anti-LepB antibody and the resulting samples were prepared for SDS-PAGE analysis with Laemmli
sample buffer supplemented with 400 mg/ml RNase A. Gels were analyzed with a Fuji FLA-3000
phosphorimager and ImageGauge V4.23 software. Quantification of protein bands was performed
using EasyQuant (in-house developed software). The fraction of full-length values (fFL)
was calculated using the formula fFL = IFL / (IFL+IA), where IFL is the quantified intensity of the full-
length protein band and IA is the quantified intensity of the arrested protein band. Experiments
were repeated in triplicate and standard errors of the mean were calculated.
In vitro transcription and translation
For the RNase treatment assay and the final large scale purification for cryo-grid, RTS 100 E.coli HY
Kit (5 PRIME) was used (transcription and translation coupled). 500 mL reaction was incubated at
30˚C for 35 min with 12.6 pmol PCR-product template generated upon the DSS-VemP construct.
RNase was added to the reaction where indicated, and incubated at 30˚C for an additional 10 min.
For the time course, the same amount of PCR-product template was used with the PURExpress In
Vitro Protein Synthesis Kit (New England Biolabs #E6800S, transcription and translation coupled).
Figure 3 continued
erythromycin (blue) molecule are shown, respectively. (g) A zoomed-in view of (f) showing the superposition of VemP (green) and hCMV (yellow) in the
C-terminal helical part including the side chains. The last residue, Q156 in case of VemP and P22 in case of hCMV, connecting to the CCA end of tRNA
is labelled.
DOI: 10.7554/eLife.25642.010
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Figure 4. Interactions of the VemP nascent chain with the ribosomal tunnel (with density shown). (a) N154 of VemP (green) stacks upon U2506(b) of the
23S rRNA (blue). (b) N154 of VemP is within hydrogen bond distance of nucleotide U2584. (c) Y150 of VemP stacks upon C2610. (d) K144 of VemP forms
a salt bridge with U747. (e) W143 of VemP stacks with R92 of uL22 (orange). (f) R139 of VemP stacks upon A752. (g) W124 of VemP stacks upon R95 of
uL22. (h) H133 of VemP interacts with K58 of uL4 (cyan). The middle panel maps the approximate locations of the interactions and includes the
sequence of VemP with critical (bold) and important (boxed green) residues highlighted (Ishii et al., 2015). In panels (a–h) the electron density for the
VemP-SRC map (mesh) is coloured according to either VemP (green), 23S rRNA (blue), uL4 (cyan) or uL22 (orange).
DOI: 10.7554/eLife.25642.011
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Figure 5. VemP stabilizes the uninduced state of the PTC to inhibit A-tRNA accommodation. (a) Conformation of U2585 and U2506 relative to VemP
(green) at the PTC of the VemP-SRC. (b) Conformation of U2585 (blue) in the VemP-SRC compared with the uninduced (pink, PDB ID 1VQ6) and
induced (tan, PDB ID 1VQN) states (Schmeing et al., 2005). (c) N154 of the upper a-helix of VemP clashes (indicated by spheres) with the induced
conformation of U2585 (Schmeing et al., 2005). (d) Conformation of human U4493 (orange, numbering according to PDB ID 5A8L and 5AJ0, being
Figure 5 continued on next page
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Reactions were incubated at 37˚C for various times (25/40/55/70/85/100 min). For western blotting,
reaction products were separated by either home-made or commercial NuPAGE 12% Bis-Tris gels
(Invitrogen, CA, USA) with 1x MOPS buffer. Proteins were blotted to nitrocellulose membrane (Carl
Roth, Germany), incubated with mouse anti FLAG M2 HRP (Sigma, Germany) and visualized by
ChemiDoc MP System (Bio-Rad).
Purification of the VemP-SRC
500 mL in vitro translation reaction was loaded onto 10–50% sucrose gradient prepared with Buffer
C (25 mM pH 7.2 HEPES-KOH, 100 mM KOAc, 10 mM Mg(OAc)2, 0.01% DDM, 1/1,000 complete
protease inhibitor (Roche, Germany), 0.2 U/mL RNase, 2 mM 2-mercaptoethanol) and centrifuged
for 3 hr in a Beckman coulter SW40 Ti swinging bucket rotor with 35,000 r.p.m. at 4˚C. Gradients
were separated on a Biocomp Gradient Station and fractions containing 70S ribosomal particles
were collected and loaded onto a Talon metal affinity chromatography column (1.5 ml resin) pre-
equilibrated in 10 mL buffer C containing 10 mg/mL bulk tRNA. The column was washed with 25 ml
buffer C until no significant absorption (OD260) could be detected in the wash fractions. The VemP-
SRC, bound to the Talon matrix by the VemP N-terminal His-tag, was eluted in 750 mL buffer C con-
taining 150 mM imidazole. The elution was pelleted for 4 hr 20 min in a Beckman Coulter TLA 120.2
fixed-angle rotor with 51,000 r.p.m. at 4˚C. 15.6 pmol VemP-SRC pellet was resuspended in ice-cold
buffer C without DDM, aliquoted and snap-frozen.
Cryo-electron microscopy and single particle reconstruction
E. coli VemP-SRC (6 OD260/mL) was applied to 2 nm pre-coated Quantifoil R3/3 holey carbon sup-
ported grids and vitrified using Vitrobot Mark IV (FEI). Data collection was performed using EM-
TOOLS (TVIPS GmbH) on a Titan Krios transmission electron microscope equipped with a Falcon II
direct electron detector (FEI) at 300kV at a pixel size of 1.084 Å and a defocus range of 1–2.5 mm.
10 frames (dose per frame of 2.5 e-/Å2) were aligned using MotionCor2 (Li et al., 2013). Power-
spectra, defocus values and astigmatism were determined with CTFFIND4 software (Rohou and Gri-
gorieff, 2015). 5735 micrographs were manually inspected in real space and in the meantime fil-
tered by threshold of resolution at 4.5 Å and astigmatism at 5% resulting in 4849 micrographs.
850,433 particles were automatically picked by Gautomatch (http://www.mrc-lmb.cam.ac.uk/kzhang/
) and single particles were processed using RELION 1.4 (Scheres, 2012). After 2D classification,
789,006 particles were subjected to 3D refinement using E. coli 70S ribosome as reference structure,
followed by several further rounds of 3D classifications, including tRNA-focused sorting (64 rounds)
and sorting (58 rounds) with a ribosome mask (Figure 1—figure supplement 2). One major class
containing 400,024 particles (62%) was further refined, resulting in a final reconstruction with an
average resolution of 2.9 Å (0.143 FSC) (Figure 1—figure supplement 3). The map was subse-
quently B-factored by EMBfactor (Fernández et al., 2008) with the FSC. Finally, the local resolution
was calculated using ResMap (Kucukelbir et al., 2014).
Molecular modeling and refinement of the VemP-SRC
The molecular model for the ribosomal proteins and rRNA of the 70S ribosome of the VemP-SRC
was based on the molecular model from cryo-EM reconstruction of the E. coli 70S ribosome (PDB ID
5JU8) (Arenz et al., 2016), except that the bL31 was based on the (PDB ID 5LZD) (Fischer et al.,
2016). The molecular model for Gln-tRNA was based on a crystal structure (PDB ID 1GSG)
(Rould et al., 1989). The molecular models were initially fitted as a rigid body into the cryo-EM den-
sity map of the corresponding stalled complex using UCSF Chimera (Pettersen et al., 2004). The
Figure 5 continued
equivalent to U4531 in PDB ID 4UG0 and 4V6X) in the hCMV-SRC compared with E. coli U2585 (blue) in the VemP-SRC. (e) The U2506(a) conformation
overlaps the binding position of an accommodated Phe-tRNA (purple) at the A-site of the PTC (Schmeing et al., 2005). (f) Conformation of U2506 in
the VemP-SRC (blue) compared with the uninduced (pink) and induced (tan) states (Schmeing et al., 2005). (g) N154 of the upper a-helix of VemP
clashes (indicated by spheres) with the induced conformation of U2506 (Schmeing et al., 2005). (h) Conformation of human U4414 (orange, numbering
according to PDB ID 5A8L and 5AJ0, being equivalent to U4452 in PDB ID 4UG0 and 4V6X) in the hCMV-SRC compared with U2506 (blue) in the VemP-
SRC. hCMV stalling peptide is shown in yellow in (d) and (h).
DOI: 10.7554/eLife.25642.012
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complete atomic model of the VemP-SRC was manually adjusted using Coot (Emsley and Cowtan,
2004) and refined using phenix.real_space_refine with restraints obtained by phenix.secondary_-
structure_restraints (Adams et al., 2010). The Phenix refined model was further refined using
REFMAC (Vagin et al., 2004) to validate the overfitting as previously described (Brown et al.,
2015) (Figure 1—figure supplement 3). The statistics of the refined model were calculated using
Molprobity (Chen et al., 2010) are presented in Table 1.
Figure 6. Model for VemP-mediated translation stalling and relief. (a–b) Schematic summarizing the molecular basis for (a) VemP-dependent translation
arrest and (b) relief of arrest via the pulling-force (indicated by arrow) on VemP protein translocation.
DOI: 10.7554/eLife.25642.013
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Figure preparation
The protein secondary structure prediction of the native VemP sequence was performed using the
MPI bioinformatics Toolkit (Alva et al., 2016) with the prediction method written by B. Rost
(Rost, 2001). Figures showing electron densities and atomic models were generated using either
UCSF Chimera (Pettersen et al., 2004) or PyMol Molecular Graphics Systems (Version 1.8 Schrö-
dinger, LLC,).
Accession codes
The cryo-electron microscopy map for the VemP-SRC has been deposited in the EMDataBank with
the accession code EMD-3713. The respective coordinates for electron-microscopy-based model of
the VemP-SRC are deposited in the ProteinDataBank (5NWY).
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Structure and function of Vms1 and Arb1 in RQC and 
mitochondrial proteome homeostasis
 Ting Su1,6, Toshiaki Izawa2,3,4,6, Matthias Thoms1, Yui Yamashita5, Jingdong Cheng1, Otto Berninghausen1, F. Ulrich Hartl3, 
Toshifumi Inada4, Walter Neupert2,3* & Roland Beckmann1*
Ribosome-associated quality control (RQC) provides a rescue 
pathway for eukaryotic cells to process faulty proteins after 
translational stalling of cytoplasmic ribosomes1–6. After dissociation 
of ribosomes, the stalled tRNA-bound peptide remains associated 
with the 60S subunit and extended by Rqc2 by addition of C-terminal 
alanyl and threonyl residues (CAT tails)7–9, whereas Vms1 catalyses 
cleavage and release of the peptidyl-tRNA before or after addition of 
CAT tails10–12. In doing so, Vms1 counteracts CAT-tailing of nuclear-
encoded mitochondrial proteins that otherwise drive aggregation 
and compromise mitochondrial and cellular homeostasis13. Here 
we present structural and functional insights into the interaction 
of Saccharomyces cerevisiae Vms1 with 60S subunits in pre- and 
post-peptidyl-tRNA cleavage states. Vms1 binds to 60S subunits 
with its Vms1-like release factor 1 (VLRF1), zinc finger and ankyrin 
domains. VLRF1 overlaps with the Rqc2 A-tRNA position and 
interacts with the ribosomal A-site, projecting its catalytic GSQ 
motif towards the CCA end of the tRNA, its Y285 residue dislodging 
the tRNA A73 for nucleolytic cleavage. Moreover, in the pre-state, we 
found the ABCF-type ATPase Arb1 in the ribosomal E-site, which 
stabilizes the delocalized A73 of the peptidyl-tRNA and stimulates 
Vms1-dependent tRNA cleavage. Our structural analysis provides 
mechanistic insights into the interplay of the RQC factors Vms1, 
Rqc2 and Arb1 and their role in the protection of mitochondria 
from the aggregation of toxic proteins.
Translational stalling in the cytoplasm of eukaryotes results in the 
dissociation of ribosomes with the peptidyl-tRNA remaining bound to 
the large subunit (60S), to which the RQC components Rqc1, listerin 
(Ltn1 in yeast), Rqc2, Cdc48 and the anti-association factor eIF6 (Tif6 
in yeast) bind1–7. Rqc2 adds CAT tails, and the E3 ligase Ltn1 ubiq-
uitylates the nascent peptide1,7–9. As a result, stalled polypeptides are 
extracted from the ribosome by the AAA-ATPase Cdc48 and delivered 
to the proteasome system for degradation2–4. However, the presence 
of CAT tails can cause aggregation of the released peptides with other 
proteins in the cytosol and also in mitochondria, where they have toxic 
effects13–16. Vms1 cleaves peptidyl-tRNA before or after CAT-tailing 
and has been shown to antagonize CAT-tail-dependent mitochondrial 
toxicity10–13. However, the molecular mechanisms by which Vms1 
antagonizes Rqc2 and acts as a peptidyl-tRNA hydrolase are poorly 
understood.
We affinity-purified Vms1–60S complexes from vms1∆ cells 
expressing Myc-tagged Vms1 lacking the C-terminal VIM domain, 
as this Cdc48-recruiting domain is dispensable for the protective and 
release activity of Vms110,13. To functionally characterize the role of 
the GSQ motif, which was suggested to be central for Vms1 pepti-
dyl-tRNA cleavage activity, we used Vms1(∆VIM) and Vms1(∆VIM/
Q295L), which has largely impaired cleavage activity10,11. The purified 
complexes contained Vms1 and 60S ribosomal proteins but, in contrast 
to complexes with wild-type (WT) Vms1, there was no Cdc48 ATPase 
(Extended Data Fig. 1a).
Cryo-electron microscopy (cryo-EM) analysis was performed with 
the purified complexes containing Vms1(∆VIM) and Vms1(∆VIM/
Q295L); classification (Extended Data Fig. 1b–e and Extended Data 
Table 1) resulted in two main reconstructions at average resolutions 
of 3.4 Å (Extended Data Fig. 2a). Both maps showed typical 60S ribo-
somal subunits with additional densities representing Tif6 near the 
sarcin–ricin loop (SRL)17 and distinct Vms1 domains at the intersub-
unit surface of the 60S subunit (Fig. 1a). Of note, we observed density 
corresponding to a tRNA and a connected nascent polypeptide chain 
only in the Vms1(∆VIM/Q295L) reconstruction. This indicates that 
the mutated GSQ construct resulted in stabilization and enrichment 
of the peptidyl-tRNA before cleavage (hereafter, ‘pre-state’), whereas 
the wild-type GSQ construct represented a state after peptidyl-tRNA 
cleavage and release (hereafter, ‘post-state’) (Fig. 1a).
The maps enabled identification and molecular model docking or 
building of three distinct Vms1 domains on the 60S subunit (Fig. 1b 
and Extended Data Fig. 2b–d). The first domain, recently defined as 
Vms1-like release factor 1 domain (VLRF1)11, and the leucine-rich 
sequence (LRS) bound in and below the A-site, interacting mainly 
with rRNA helices 69 and 71 (H69 and H71) and the peptidyl-tRNA. 
The finger-like domain carrying the catalytically active GSQ loop 
reached towards the CCA end of the tRNA (Fig. 1c). The conformation 
of the VLRF1 domain is essentially the same in pre- and post-states, 
with a small shift towards the P site in the presence of peptidyl-tRNA 
(Extended Data Fig. 2e). The second domain containing a zinc fin-
ger domain of Vms1 interacted with Tif6 (Fig. 1d and Extended Data 
Fig. 2c), and the third domain, consisting of the Vms1 ankyrin-repeat 
domain (AnkR) and the coiled-coil domain (CC; comprising one 
helix), bound between the rRNA H101 and the rRNA expansion seg-
ment 27 (ES27) (Fig. 1d). The CC domain was only partially visible 
and pointed towards the ribosomal tunnel exit where the following 
VIM domain would coordinate the Cdc48 ATPase during peptide 
extraction (Extended Data Fig. 2f). To test the contribution of the 
AnkR and CC domains to the Vms1–60S interaction we generated 
deletion constructs. In contrast to deletion of the CC domain, deletion 
of the AnkR domain reduced the yield of co-purified 60S subunits, 
confirming its contribution to the affinity of Vms1 for the 60S subu-
nit (Extended Data Fig. 2g). However, Vms1(∆AnkR), Vms1(∆ZnF) 
and the double deletion (Vms1(∆AnkR/∆ZnF)) could still rescue 
the growth defect of vms1∆ltn1∆ cells under respiratory conditions, 
prevented formation of SDS-insoluble aggregates of a mitochondrial 
nonstop GFP (NS-mtGFP) reporter and allowed the maturation of the 
mitochondrial Rieske protein (Rip1), an indicator of mitochondrial 
proteome integrity13 (Extended Data Fig. 2h–j). Although this indi-
cates that the VLRF1 domain alone is sufficient to provide the affinity 
for functional activity, the canonical Vms1 binding to the 60S subunit 
is established by a tri-modal interaction pattern consisting mainly of 
the VLRF1 domain in the ribosomal A-site, assisted by the ZnF and 
AnkR domains.
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The peptidyl-tRNA in the pre-state particle (tRNAVms1) was found 
between the A- and P-sites (Fig. 1d) with its CCA end coordinated 
by the ribosomal P loop and clearly connected to a nascent peptide 
(Extended Data Fig. 2c). Although disordered, the GSQ loop region 
of the VLRF1 domain (R288–G309) was positioned near the CCA, 
similar to the canonical termination factor eRF1 (Fig. 1d). However, the 
catalytic loop of Vms1 displayed a unique interaction with the tRNA, 
as its conserved Y285 stacked with the tRNA base in position 72 (here 
C72). As a result, the base in position 73 (in most cases, A73) is dis-
placed and the phosphate backbone is exposed (Fig. 2a, b and Extended 
Data Fig. 2k). As this tyrosine is missing in canonical release factors 
(Fig. 2b), we tested its importance in an in vitro release assay10. After 
translation of a non-stop RQC substrate with a 3×Flag tag (NS-3×Flag) 
in a cell-free extract generated from vms1∆ski2∆ cells, the stalled pep-
tidyl-tRNA can be released by the addition of purified recombinant 
Vms1 (see Methods). As expected, with wild-type Vms1 we observed 
a decrease of the peptidyl-tRNA substrate signal and detection of a 
lower-molecular-weight signal representing the released peptide. These 
combined signals are indicative of peptidyl-tRNA cleavage (Fig. 2c). 
Compared with wild-type Vms1, Vms1(Q295L) and Vms1(Y285A) 
mutants displayed reduced release activity (described previously for 
Q295L10). Notably, the Vms1(Q295L/Y285A) double mutation resulted 
in a complete loss of activity (Fig. 2c). This supports the notion that 
Y285 contributes to the catalytic activity of Vms1 but in a mechanisti-
cally distinct way from canonical release factors. Notably, the human 
homologue ANKZF1 was recently discovered to display tRNA nuclease 
activity12, which releases the polypeptide with some nucleotides still 
attached. Therefore, we tested Vms1 for nuclease activity by adding 
RNase A in our in vitro assay to degrade any remaining peptide-bound 
oligonucleotide. Peptidyl-tRNA and peptide signals disappeared 
and collapsed to the molecular weight of the free peptide (Fig. 2d). 
Consistent with a recent report18, this shows that Vms1 is also a tRNA 
nuclease, and that its cleavage mechanism involves remodelling and 
cleavage of the ribose-phosphate backbone of the tRNA by Y285 and 
the GSQ motif, respectively.
In vivo, the function of Vms1 in protecting mitochondria is depend-
ent on its Rqc2-antagonizing activity. Overexpression of Vms1 triggers 
displacement of Rqc2 from ribosomal subunits13, and we observed a 
direct steric clash between the Rqc2 A-tRNA (A-tRNARqc2) complex 
and the Vms1 VLRF1 domain with the tRNAVms1 (Fig. 2e). Therefore, 
we tested in vivo whether the Vms1(Q295L), Vms1(Y285A) or 
Vms1(Q295L/Y285A) mutants were able to rescue the growth defect of 
vms1∆ltn1∆ cells under respiratory conditions. Indeed, Vms1(Q295L) 
and Vms1(Y285A) rescued the growth defect and enabled maturation 
of the mitochondrial Rip1 protein; however, Vms1(Q295L/Y285A), 
which completely lacked release activity, could not rescue the growth 
b
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Fig. 1 | Structural analysis of Vms1-bound 60S ribosomal subunits 
in pre- and post-cleavage states of peptidyl-tRNA. a, Cryo-EM 
reconstructions of the Vms1–60S particles in two orientations. Top 
row, the pre-state purified via Vms1(∆VIM/Q295L); bottom row, the 
post-state purified via Vms1(∆VIM). Electron density is displayed at 
multiple contour levels (see Methods). b, Molecular model of the pre-state 
complex with labelled Vms1 LRS and VLRF1 domains, ZnF, AnkR and 
CC domains. c, Magnified view of the area outlined in b, illustrating the 
interaction of the VLRF1 domain (orange) with peptidyl-tRNA (blue) 
and 25S rRNA helix H69 (pink) from three angles. The disordered loop 
harbouring the mutated GSQ motif (R288–G309) is indicated as a dashed 
line. The domain organization of Vms1 is shown below. d, Left to right: 
interaction of the Vms1 ZnF domain with Tif6; the AnkR-CC domain 
bound between 25S rRNA helices H101 and ES27; comparison of peptidyl-
tRNAVms1 (pep–tRNAVms1) and canonical A-site and P-site tRNA (Protein 
Data Bank (PDB) ID 5GAK) in two orientations; and superposition of the 
VLRF1 domain (the disordered loop with the GSQ motif in dashed line) 
and the release factor eRF1 (PDB ID 5LZU).
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defect and prevented maturation of Rip1 (Fig. 2f and Extended Data 
Fig. 2j). Consistently, the formation of SDS-insoluble aggregates of the 
NS-mtGFP reporter in vms1∆ cells could be fully prevented by overex-
pression of wild-type Vms1 and partially prevented by Vms1(Q295L) 
or Vms1(Y285A); however, Vms1(Q295L/Y285A) did not prevent for-
mation of the aggregates (Fig. 2g and Extended Data Fig. 2g). Taken 
together, the Rqc2-antagonizing activity of Vms1 in mitochondrial 
RQC may be partially provided by steric competition with Rqc2; 
however, it also requires peptide-release activity.
Surprisingly, a large class of the Vms1 pre-state particles contained 
an additional protein, identified as the ABCF-type ATPase Arb1 
(Fig. 3a and Extended Data Figs. 1d, 3a–c), which is known to be 
involved in ribosome biogenesis and to co-purify with Vms119. Its 
two nucleotide-binding domains (NBDs) were located in the ribo-
somal E-site and its leg domain (LD) protruded towards the tRNA 
CCA end (Fig. 3a–e and Extended Data Fig. 3d), similar to bacterial 
ABCF-type ATPases on 70S ribosomes20–22. Arb1 NBD1 contacted 
the L1 stalk (mainly uL1) whereas NBD2 interacted with uL5, and 
both NBDs interacted with eL42. The LD ran parallel to rRNA H68 
and its loop reached the acceptor arm of the tRNA opposite the Vms1 
GSQ loop (Fig. 3b, c). The two NBDs adopted a flexible but clearly 
open-state conformation (Extended Data Fig. 3e, f); nevertheless, it 
was possible to build a de novo molecular model of the LD (Fig. 3b, c 
and Extended Data Fig. 3c, d). Similar to Vms1, Arb1 would steri-
cally clash with Rqc2 (Extended Data Fig. 3g), however, overexpres-
sion of Arb1 did not dissociate Rqc2 from ribosomes13 (Extended 
Data Fig. 3h).
Arb1 interacted with the tRNAVms1 by forming an unusual triple 
stack comprising Y346 in the loop (A343–Y346) of the Arb1 LD, the 
nucleobase 73 of the tRNA (here A73) and A2971 of the 25S rRNA 
(A2602 in Escherichia coli) (Fig. 3d, e and Extended Data Fig. 3i). This 
requires rotation of A2971 by about 180° and stabilizes the dislocated 
A73 of the tRNA in a distinct position (Extended Data Fig. 3j). The 
tRNA phosphate backbone is thereby exposed to Vms1 VLRF1 and 
to the conformation-altered loop S103–Q111 of uL16 near T345 of 
Arb1 (Extended Data Fig. 3o). To test whether Arb1 contributes to 
peptide release, we used our in vitro assay with recombinant Arb1 and 
cell extracts from either vms1∆ski2∆ or vms1∆ arb1 degron cells23 
(Fig. 3f and Extended Data Fig. 3k, l). Addition of Arb1 to varying 
amounts of Vms1 increased release of peptide, indicating that Arb1 
can indeed stimulate the release activity of Vms1 (Fig. 3f and Extended 
Data Fig. 3l). Next, we tested the function of Arb1 in the context of 
mitochondrial RQC in vivo. Overexpression of wild-type Arb1, but 
not of mutant constructs deficient in ATP binding (Arb1(G229D/
G230E/G519D); hereafter, Arb1(DED))19 or carrying a truncated LD 
domain (Arb1(∆343–348)), or Arb1(Y346A), could rescue the growth 
defect and the Rip1 maturation defect of vms1∆ltn1∆ cells (Fig. 3g, h). 
These results support a function of Arb1 in mitochondrial RQC. 
Furthermore, as the assays were also performed in vivo in vms1∆ cells, 
they also suggest that Arb1 has Vms1-independent Rqc2-antagonizing 
activity. To test for a role of Arb1 in cytosolic RQC, we used an in vivo 
reporter assay, in which expression of a nonstop cytoplasmic GFP 
(NS-cGFP) construct in ltn1∆ and vms1∆ltn1∆ cells results in the 
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Fig. 2 | Vms1 exhibits nuclease activity, which is required to antagonize 
Rqc2. a, Comparison of a canonical P-tRNA from eIF5A-bound ribosomes 
(left) and the tRNAVms1 in the pre-state (right). b, Sequence alignment of 
yeast Vms1, human ANKZF1, yeast eRF1, human eRF1 and Aeropyrum 
pernix aRF1, starting at the indicated residue number. The catalytic loop 
and residues Y285 and Q295 are outlined. c, Yeast in vitro release reaction 
of the arrested peptides translated from a non-stop RQC reporter mRNA 
NS-3×Flag in lysate from vms1∆ski2∆ cells. Buffer, Vms1(WT) or the 
indicated Vms1 mutants were added to a cycloheximide-treated (stopped) 
translation reaction and incubated for 0, 2 or 5 min at 25 °C. Top, samples 
were analysed by immunoblotting with Flag antibody. Bottom, a longer 
exposure of the low molecular weight region of the same blot. CCA, CCA 
from the tRNA 3′ end; pep, peptide; * and ** indicate peptidyl-tRNA and 
free peptide from the colliding ribosome, respectively. d, Yeast in vitro 
release reaction as described in c. Samples were incubated with buffer, 
Vms1(Q295L/Y285A) or Vms1(WT) at 25 °C for 5 min. The Vms1(WT) 
samples were further incubated with either RNase A or H2O for 5 min 
at room temperature. e, Model illustrating the steric clash of the Vms1 
VLRF1 domain and tRNAVms1 with Rqc2, P-tRNARqc2 and A-tRNARqc2 
(Electron Microscopy Data Bank 2812) on the 60S subunit. f, The 
vms1∆ltn1∆ strain was transformed with empty vector or constructs 
expressing Vms1(WT) or the indicated mutants expressed from the 
endogenous VMS1 promoter. Cells were spotted on YPD or YPG plates 
and grown at 37 °C. g, Vms1∆ cells expressing the NS-mtGFP reporter 
and overexpressing (OE) indicated Myc-tagged Vms1 constructs from the 
GPD1 promoter. Cell extracts were analysed by immunoblotting with the 
indicated antibodies. SDS-insoluble aggregates are shown with a longer 
exposure (top).
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overexpression of Arb1 prevented aggregate formation, whereas 
Arb1(DED) and Arb1(∆343–348) had very limited effects, despite 
their interactions with Vms1–60S (Fig. 3i and Extended Data Fig. 3m, 
n). Notably, the Arb1(Y346A) mutation displayed a dominant-negative 
phenotype upon overexpression, and was therefore not analysed fur-
ther. We conclude that Arb1 has a general function in RQC, most 
likely through stimulation of the peptidyl-tRNA-release activity of 

















































































































































Fig. 3 | Arb1 is genetically and physically linked to RQC and stimulates 
the nuclease activity of Vms1. a, Cryo-EM reconstruction (top left) and 
molecular model (top right) of pre-state Vms1–60S particles containing 
Arb1. See Methods for density contour levels used. Bottom, domain 
organization of Arb1. NTD, N-terminal domain. b, Positioning and 
interaction of Arb1 with the 60S subunit. c, Same as b, rotated 180° and 
shown without the 60S model. The Arb1 LD loop near the tRNA CCA 
end juxtaposed with the Vms1 GSL loop. d, tRNAVms1 in the presence of 
Arb1. e, Triple-stack model of Arb1 Y346, 25S rRNA A2971 and tRNA 
nucleobase A73. f, Yeast in vitro release reaction of the arrested peptides 
translated from the NS-3×Flag reporter mRNA in a vms1∆ arb1::degron 
lysate depleted for Arb1, incubated for 0, 2 or 5 min at 25 °C. Vms1 and 
Arb1 were added at 1 to 5 (Vms1 + Arb1) or 1 to 25 (Vms1 1/5 + Arb1) 
molar ratios. Bottom, same blot with a longer exposure. g, vms1∆ltn1∆ 
cells overexpressing indicated Arb1–Myc constructs from the GPD1 
promoter were grown on YPD or YPG plates at 37 °C. h, vms1∆ltn1∆ 
cells transformed with indicated Arb1–Myc constructs (see g) or 
vms1∆ltn1∆rqc2∆ cells were grown at 30 °C. Cell extracts were analysed 
by immunoblotting with indicated antibodies. i-Rip1, intermediate 
Rip1; m-Rip1, mature Rip1. i, vms1∆ltn1∆ cells expressing the NS-cGFP 
reporter and overexpressing indicated Arb1–Myc constructs. Cell extracts 
were analysed by immunoblotting with indicated antibodies. Top blot is a 






























Fig. 4 | Mechanistic model of Vms1, Rqc2 and Arb1 activities in RQC. 
Clockwise, from top left. After dissociation of the 80S ribosome, the 
peptidyl-tRNA bound 60S subunit is recognized by Rqc2 to initiate CAT-
tailing. This is accompanied by binding of Rqc1 and Ltn1, and recruitment 
of the Cdc48 peptide extraction machinery (Cdc48-UN). The CAT-
tailing process can be terminated at variable points by Vms1 competing 
with Rqc2 and nucleolytic release of peptidyl-tRNA. This may be aided 
by positioning and remodelling of the tRNA by Arb1. Accumulation of 
toxic CAT-tailed proteins in the mitochondrial matrix is prevented by the 
concerted activity of Ltn1-triggered proteasomal degradation and by the 
activity of Vms1 on the mitochondrial surface (Extended Data Fig. 4). 
Arb1 may be able to dislocate the deacylated tRNA and, after dissociation 
of Vms1 and Tif6, the rescued 60S subunit can be used for another round 
of translation. Sdo1 and Efl1 are Tif6-release factors in yeast (the human 
equivalents are SBDS and EFL1, respectively)24.
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bacterial ABCF ATPases MsrE and VmlR21,22, Arb1 may switch from 
the observed open state to a closed state on ATP binding and hydrolysis. 
We therefore speculate that Arb1 may also dislocate tRNA from the 60S 
subunit and have a role in the extraction of the tRNA before or after 
cleavage (Extended Data Fig. 3p).
In summary, we suggest a mechanistic model for RQC, in which 
Rqc2-dependent CAT-tailing can be terminated by nucleolytic Vms1 
and Arb1, and these factors cooperate to antagonize CAT-tail-driven 
mitochondrial toxicity (Fig. 4 and Extended Data Fig. 4).
Online content
Any methods, additional references, Nature Research reporting summaries, 
source data, extended data, supplementary information, acknowledgements, peer 
review information; details of author contributions and competing interests; and 
statements of data and code availability are available at https://doi.org/10.1038/
s41586-019-1307-z.
Received: 1 October 2018; Accepted: 16 May 2019;  
Published online 12 June 2019.
 1. Bengtson, M. H. & Joazeiro, C. A. Role of a ribosome-associated E3 ubiquitin 
ligase in protein quality control. Nature 467, 470–473 (2010).
 2. Brandman, O. et al. A ribosome-bound quality control complex triggers 
degradation of nascent peptides and signals translation stress. Cell 151, 
1042–1054 (2012).
 3. Defenouillère, Q. et al. Cdc48-associated complex bound to 60S particles is 
required for the clearance of aberrant translation products. Proc. Natl Acad. Sci. 
USA 110, 5046–5051 (2013).
 4. Verma, R., Oania, R. S., Kolawa, N. J. & Deshaies, R. J. Cdc48/p97 promotes 
degradation of aberrant nascent polypeptides bound to the ribosome. eLife 2, 
e00308 (2013).
 5. Brandman, O. & Hegde, R. S. Ribosome-associated protein quality control.  
Nat. Struct. Mol. Biol. 23, 7–15 (2016).
 6. Joazeiro, C. A. P. Mechanisms and functions of ribosome-associated protein 
quality control. Nat. Rev. Mol. Cell Biol. 20, 368–383 (2019).
 7. Shen, P. S. et al. Rqc2p and 60S ribosomal subunits mediate mRNA-
independent elongation of nascent chains. Science 347, 75–78 (2015).
 8. Kostova, K. K. et al. CAT-tailing as a fail-safe mechanism for efficient 
degradation of stalled nascent polypeptides. Science 357, 414–417  
(2017).
 9. Osuna, B. A., Howard, C. J., Kc, S., Frost, A. & Weinberg, D. E. In vitro analysis of 
RQC activities provides insights into the mechanism and function of CAT tailing. 
eLife 6, e27949 (2017).
 10. Zurita Rendón, O. et al. Vms1p is a release factor for the ribosome-associated 
quality control complex. Nat. Commun. 9, 2197 (2018).
 11. Verma, R. et al. Vms1 and ANKZF1 peptidyl-tRNA hydrolases release nascent 
chains from stalled ribosomes. Nature 557, 446–451 (2018).
 12. Kuroha, K., Zinoviev, A., Hellen, C. U. T. & Pestova, T. V. Release of ubiquitinated 
and non-ubiquitinated nascent chains from stalled mammalian ribosomal 
complexes by ANKZF1 and Ptrh1. Mol. Cell 72, 286–302 (2018).
 13. Izawa, T., Park, S. H., Zhao, L., Hartl, F. U. & Neupert, W. Cytosolic protein Vms1 
links ribosome quality control to mitochondrial and cellular homeostasis. Cell 
171, 890–903 (2017).
 14. Choe, Y. J. et al. Failure of RQC machinery causes protein aggregation and 
proteotoxic stress. Nature 531, 191–195 (2016).
 15. Defenouillère, Q. et al. Rqc1 and Ltn1 prevent C-terminal alanine-threonine tail 
(CAT-tail)-induced protein aggregation by efficient recruitment of Cdc48 on 
stalled 60S subunits. J. Biol. Chem. 291, 12245–12253 (2016).
 16. Yonashiro, R. et al. The Rqc2/Tae2 subunit of the ribosome-associated quality 
control (RQC) complex marks ribosome-stalled nascent polypeptide chains for 
aggregation. eLife 5, e11794 (2016).
 17. Gartmann, M. et al. Mechanism of eIF6-mediated inhibition of ribosomal 
subunit joining. J. Biol. Chem. 285, 14848–14851 (2010).
 18. Yip, M. C. J. et al. Mechanism for recycling tRNAs on stalled ribosomes. Nat. 
Struct. Mol. Biol. 26, 343–349 (2019).
 19. Dong, J., Lai, R., Jennings, J. L., Link, A. J. & Hinnebusch, A. G. The novel 
ATP-binding cassette protein ARB1 is a shuttling factor that stimulates 40S and 
60S ribosome biogenesis. Mol. Cell. Biol. 25, 9859–9873 (2005).
 20. Chen, B. et al. EttA regulates translation by binding the ribosomal E site and 
restricting ribosome-tRNA dynamics. Nat. Struct. Mol. Biol. 21, 152–159 (2014).
 21. Crowe-McAuliffe, C. et al. Structural basis for antibiotic resistance mediated by 
the Bacillus subtilis ABCF ATPase VmlR. Proc. Natl Acad. Sci. USA 115, 
8978–8983 (2018).
 22. Su, W. et al. Ribosome protection by antibiotic resistance ATP-binding cassette 
protein. Proc. Natl Acad. Sci. USA 115, 5157–5162 (2018).
 23. Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T. & Kanemaki, M. An 
auxin-based degron system for the rapid depletion of proteins in nonplant cells. 
Nat. Methods 6, 917–922 (2009).
 24. Weis, F. et al. Mechanism of eIF6 release from the nascent 60S ribosomal 
subunit. Nat. Struct. Mol. Biol. 22, 914–919 (2015).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional 
claims in published maps and institutional affiliations.
© The Author(s), under exclusive licence to Springer Nature Limited 2019
5 4 2  |  N A T U R E  |  V O L  5 7 0  |  2 7  J U N E  2 0 1 9
LETTER RESEARCH
METHODS
Data reporting. No statistical methods were used to predetermine sample size. The 
experiments were not randomized. The investigators were not blinded to allocation 
during experiments and outcome assessment.
Yeast strains and growth conditions. Strains used in this study were derived from 
BY4742 (MATα his3∆1 leu2∆0 lys2∆0 ura3∆0). W303 (MATα ade2-1 his3-11,15 
leu2-3 trp1-1 ura3-1 can1-100) was used for overexpression and purification of 
Arb1. Standard gene disruption and tagging methods were applied to generate 
the S. cerevisiae strains25,26 and strains used in this study are listed in Extended 
Data Table 2. Cells were grown in YP rich medium or synthetic complete (SC) 
medium at 30 °C or 37 °C. The respective media contained 2% glucose (YPD, SCD), 
3% galactose (YPGal, SCGal), 2% raffinose plus 2% galactose (SCRafGal) or 3% 
glycerol (YPG).
Growth analysis. Cells were grown in SCD or YPD medium at 30 °C and spot-
ted in tenfold dilution steps on YPD (fermentable carbon source) or YPG plates 
(non-fermentable carbon source). YPD and YPG plates were incubated for two 
days and for three-to-four days, respectively.
Plasmid construction. Plasmids were constructed using standard recombinant 
DNA techniques, Gibson assembly cloning (Gibson Assembly kit, NEB) or FX 
cloning27,28 and were verified by sequencing. The S. cerevisiae plasmids used 
and constructed in this study are listed in Extended Data Table 3. The plasmid 
p7XC3GH (pET26b-based, a gift from R. Dutzler and E. Geertsma (Addgene 
plasmid 47066)) was used to generate the E. coli expression vectors harbour-
ing Vms1(WT), Vms1(Q295L), Vms1(Y285A) or Vms1(Q295L/Y285A) with a 
C-terminal 3C–GFP–His10 tag for protein purification. The plasmid pEX-A2-3FRP 
was used to generate a linear DNA template for the truncated mRNA harbouring a 
3×Flag tag and lacking a stop codon (NS-3×Flag) for the yeast in vitro assays. The 
construct was based on the reported pEX-A2-His-HA-uL4(1–86)-(CGA-CCG)2 
construct29 (HA, haemagglutinin). A 3×Flag tag was inserted in the uL4 sequence 
to generate the His-HA-uL4(1–37)-3×Flag-uL4(38–86)-(CGA-CCG)2 construct.
Protein expression and purification. The Vms1 constructs fused to a C-terminal 
3C–GFP–His10 tag were expressed in E. coli BL21 (DE3) cells. Cells were grown in 
LB medium supplemented with kanamycin (35 µg/ml) at 37 °C until they reached 
an OD600 of ~0.6 and were subsequently shifted to 18 °C. Protein expression was 
induced by the addition of 0.5 mM IPTG and cultures were grown for 15–16 h at 
18 °C. Cell pellets were resuspended in lysis buffer containing 20 mM HEPES-
NaOH pH 8.0, 300 mM NaCl, 5% glycerol, 0.01% NP40 and supplemented with 
20 mM imidazole, cOmplete Protease Inhibitor Cocktail (Roche) and 2 mM ATP 
and lysed with a M-110L Microfluidizer (Microfluidics). The lysate was cleared by 
centrifugation at 19,000 r.p.m. for 30 min at 4 °C and the supernatant was incubated 
with Talon metal-affinity resin (TaKaRa) at 4 °C for 1 h on a turning wheel. The 
resin was extensively washed with lysis buffer supplemented with 20 mM imida-
zole. The Talon beads were incubated for 1 h at 4 °C with lysis buffer supplemented 
with 3C protease. The eluted samples were concentrated with Amicon Ultra 
centrifugal filter (Millipore) and further purified via size-exclusion chromatog-
raphy (Superose 6 Increase, GE Healthcare) in buffer containing 20 mM HEPES-
KOH pH 7.5, 100 mM KOAc, 2.5 mM Mg(OAc)2, 5% glycerol and 2 mM DTT. 
Vms1-containing fractions were pooled, concentrated and flash-frozen in liquid 
nitrogen. Aliquots were stored at −80 °C.
Arb1 was overexpressed in S. cerevisiae (W303). Therefore, a YEplac112-Leu2d-
GAL1-10-Arb1-TEV-ProtA construct was generated. Cell cultures were grown in 
SCD medium lacking leucine at 30 °C and overexpression was induced by shifting 
cells to YPGal medium for 20 h at 30 °C. Cells were disrupted by cryo-milling 
using a 6970EFM Freezer/Mill (SPEX Sample prep) and the cell powder was resus-
pended in buffer containing 20 mM HEPES pH 7.5, 200 mM NaCl, 10 mM KCl, 
5 mM MgCl2, 5% glycerol, 0.01% NP40, 1 mM DTT supplemented with cOmplete 
Protease Inhibitor Cocktail (Roche). The lysate was cleared by centrifugation at 
4,000 r.p.m., 4 °C for 20 min and 17,500 r.p.m., 4 °C for 25 min. IgG Sepharose 
6 Fast Flow resin (GE Healthcare) was added to the supernatant and incubated for 
2 h at 4 °C on a turning wheel. The beads were extensively washed with lysis buffer 
and the sample was released from the beads by incubation with TEV protease for 
90 min at 23 °C. The eluate was concentrated and further purified by size-exclusion 
chromatography (Superdex 200 Increase 10/300 GL, GE Healthcare) in buffer 
containing 20 mM HEPES-KOH pH 7.5, 100 mM KOAc, 2.5 mM Mg(OAc)2, 5% 
glycerol and 2 mM DTT. Arb1-containing fractions were pooled and concentrated 
with an Amicon Ultra centrifugal filter (Millipore). Aliquots were flash-frozen in 
liquid nitrogen and stored at −80 °C.
Yeast in vitro translation and release assay. Extracts were prepared as previously 
described29. The vms1∆ arb1::degron culture was treated with 500 µM auxin (final 
concentration) for 60 min to degrade Arb1–sAid–HA23. The linear DNA template 
for the RQC reporter mRNA NS–3×Flag was prepared by PCR using primers 
F (GGCCGCAAGCTAATACGACTCAC) and R (AGCCTTTTCAGAAACAGC) 
and the plasmid 3FRP (see Plasmid construction) as PCR template. The mRNA 
harbouring His-HA-uL4(1–37)-3×Flag-uL4(38–74) truncation was subsequently 
generated by T7 mMessage mMachine Kit (Thermo Fisher). The extract was 
supplemented with 0.8 mM CaCl2 and treated with MNase S7 for 15 min at 
room temperature. The reaction was stopped by the addition of EGTA to a final 
concentration of 2 mM. The extract was then supplemented with buffers29 and 
80 ng mRNA per µl extract, and incubated for 45 min at 17 °C. Translation was 
stopped by adding cycloheximide (100 µg/ml final concentration) to the reaction. 
The reaction mix was subsequently divided on ice into various tubes containing 
buffer, Vms1(WT) or Vms1 mutants with or without Arb1. After initial sampling, 
reaction aliquots were further incubated at 25 °C and sampled at specified time 
points. When RNase A treatment is indicated, the sample was incubated with 
1 µg RNase A (Qiagen) at room temperature for another 5 min. All samples were 
immediately quenched in Laemmli sample buffer and flash-frozen in liquid nitro-
gen. Proteins were separated by SDS–PAGE (12% NuPAGE, Thermo Fisher), and 
3×Flag-tagged translation products were visualized by immunoblotting with a 
monoclonal Flag antibody (A8592, Sigma-Aldrich).
Protein sequence alignment. Indicated protein sequences were obtained from 
Uniprot (P62495, Q9YAF1, Q9H8Y5 and Q04311), aligned via T-Coffee30,31  
followed by manual adjustments and visualized by BoxShade (https://embnet.
vital-it.ch/software/BOX_form.html).
Quantification of Vms1 VLRF1 domain displacement. The spatial distance 
between α-carbon atoms of the same residues in the pre- and post-states of Vms1-
VLRF1 models was measured and visualized using the PyMol Molecular Graphics 
Systems (v.1.8, Schrödinger) modevectors script32.
Isolation of Vms1–60S complex for cryo-EM. Vms1∆ cells expressing 
Vms1(∆VIM)–3C–3×Myc or Vms1(∆VIM/Q295L)–3C–3×Myc from the GPD1 
promoter were grown to log phase in SCD medium at 30 °C. In brief, 300 OD600 
units of yeast cells (one OD600 unit corresponds to the amount of yeast cells pres-
ent in 1 ml of a culture with an optical density of 1 at 600 nm) were collected and 
divided into two 2-ml test tubes. Cells in each tube were washed once with ice-cold 
water and resuspended in 400 µl lysis buffer containing 20 mM HEPES-KOH 
pH 7.4, 100 mM KOAc, 10 mM MgCl2, 0.5 mM DTT, 1 mM PMSF and cOm-
plete Protease Inhibitor Cocktail (Roche). Cells were lysed by agitation with glass 
beads followed by addition of 400 µl lysis buffer containing 1% Triton X-100. After 
incubation for 10 min on ice, insoluble material was removed by centrifugation at 
17,000g for 10 min at 4 °C. Lysates (1.3 ml) were collected and incubated with Myc 
monoclonal antibody (Max Planck Institute of Biochemistry) and 22.5 µl of protein 
A sepharose CL-4B (GE Healthcare) for 2 h at 4 °C. After removal of supernatant, 
the immunoprecipitates were washed with 700 µl wash buffer (20 mM HEPES-
KOH pH 7.4, 100 mM KOAc, 10 mM MgCl2, 0.5 mM DTT) containing 0.5% Triton 
X-100. This washing step was repeated four times. The immunoprecipitates were 
then washed with 400 µl wash buffer. This washing step was repeated three times. 
Immunoprecipitates were incubated in 40 µl elution buffer containing 20 mM 
HEPES-KOH pH 7.4, 100 mM KOAc, 10 mM MgCl2, 0.5 mM DTT, 0.1 mM 
Triton X-100 and 0.4 units of His-PreScission Protease (Max Planck Institute of 
Biochemistry) for 30 min at 4 °C to elute Vms1–ribosome complexes. The complex 
was crosslinked with 0.02% glutaraldehyde for 15 min on ice before preparation of 
the grids for cryo-EM analyses.
SDS–PAGE and immunoblotting. SDS–PAGE and immunoblotting were per-
formed as described previously13. The Odyssey imaging system (LI-COR) and 
Image Studio Lite (LI-COR), ImageQuant LAS 4000 Mini (GE Healthcare) or 
Amersham Imager 600 (GE Healthcare) were used for signal detection.
Immunoprecipitation of Vms1–60S complex for biochemical analysis. Cells 
expressing C-terminally Myc tagged Vms1 or its mutant variants from the GPD1 
promoter were grown to log phase in SCD medium at 30 °C. Cells (100 OD600 units) 
were collected, washed once with ice-cold water and resuspended in 500 µl lysis 
buffer. Cells were lysed by agitation with glass beads followed by addition of 500 µl 
lysis buffer containing 1% Triton X-100. After incubation for 10 min on ice, insol-
uble material was removed by centrifugation at 17,000g for 10 min at 4 °C. Lysates 
(800 µl) were collected and incubated with Myc monoclonal antibody (Max Planck 
Institute of Biochemistry) and 15 µl of protein A sepharose CL-4B (GE healthcare) 
for 2 h at 4 °C. After removal of supernatant, the immunoprecipitates were washed 
with 700 µl of wash buffer containing 0.5% Triton X-100. This washing step was 
repeated four times. The immunoprecipitates were then washed once with 400 µl of 
wash buffer. Immunoprecipitates were eluted with 40 µl of SDS sample buffer and 
analysed by SDS–PAGE, Coomassie brilliant blue staining and immunoblotting.
Sucrose density gradient analysis. Sucrose density gradient analysis was per-
formed as described previously13. The cells were grown in SCD medium at 30 °C. 
Proteins were precipitated with trichloroacetic acid, solubilized in urea sample 
buffer and analysed by SDS–PAGE and immunoblotting.
Electron microscopy and image processing. In brief, 2-nm pre-coated R3/3 
holey carbon supported copper grids (Quantifoil) were glow discharged at 
2 × 10−1 mbar for 20 s. Vms1(∆VIM/Q295L) or Vms1(∆VIM) pullout (3.5 µl) 
was directly applied onto each grid, blotted for 2–3 s at 4 °C and plunge-frozen in 
liquid ethane using a Vitrobot Mark IV (FEI Company). Grids were screened for 
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ice quality and cryo-EM data were acquired on a Titan Krios transmission electron 
microscope (FEI Company) at 300 kV under low-dose conditions (2.8 e− Å−2 per 
frame) with a nominal pixel size of 1.084 Å per pixel on the object scale using the 
semi-automated software EM-TOOLS (TVIPS). Micrographs (9,845 and 7,875, 
respectively) of Vms1(∆VIM/Q295L) and Vms1(∆VIM) pullouts were collected on 
a Falcon II direct electron detector at nominal defocus ranges from −1.1 to −2.3 µm, 
respectively. Original image stacks of ten frames were aligned, summed and 
drift-corrected using MotionCor233. Contrast-transfer-function (CTF) parameters 
and resolution were estimated for each micrograph using Gctf34. Micrographs with 
an estimated resolution better than 5 Å and astigmatism below 5% were manually 
inspected in real space for ice contamination or carbon rupture, which resulted in 
9,642 and 7,361 micrographs for Vms1(∆VIM/Q295L) and Vms1(∆VIM) datasets, 
respectively. An initial particle picking was performed in a template-free manner 
on 1,000 micrographs of Vms1(∆VIM) dataset by Gautomatch (http://www.mrc- 
lmb.cam.ac.uk/kzhang/) followed by a two-dimensional classification using 
RELION 2.135,36. Class averages from ten various two-dimensional views were sub-
sequently used as templates to pick particles from all inspected micrographs and 
resulted in 1,293,500 and 757,224 particles for Vms1(∆VIM) and Vms1(∆VIM/
Q295L) datasets, respectively. These particles were then two-dimensional classified, 
three-dimensional refined and three-dimensional classified as shown in Extended 
Data Fig. 1 using RELION v.2.135,36.
Model building and refinement. The ribosomal large subunit 60S was built on 
the basis of the yeast cryo-EM structure (PDB 5GAK). The yeast Vms1 crystal 
structure containing the LRS–ZnF–VLRF1 domains (PDB 5WHG) was separated 
to LRS–VLRF1 and ZnF and docked into the corresponding densities. The Vms1 
AnkR domain and Arb1 were modelled on the basis of homology structures using 
SWISS-MODEL37; a designed ankyrin repeat protein crystal structure (PDB 6F5E) 
was used for Vms1 AnkR, and Pyrrococcus furiosus RNase-L inhibitor (RLI) crystal 
structure (PDB 1YQT) and E. coli EttA cryo-EM structure (PDB 3J5S) were used 
for Arb1. Model building was conducted by using Coot38. The local resolutions of 
the RNase H-like fold (β-sheet flanked by helices) within the Vms1 VLRF1 domain 
and the Arb1 LD were around 4–4.5 Å. In these regions, the density enabled the 
modelling of side chains, in particular aromatic residues including the Vms1 Y285 
and the Arb1 Y346. The Tif6 model (PDB 5T62) was directly docked into its cor-
responding density with UCSF Chimera39.
The final models were real-space refined at resolutions of 3.4 Å, 3.6 Å and 3.4 Å 
for pre-state (Vms1(∆VIM/Q295L)) without Arb1, pre-state with Arb1 and post-
state (Vms1(∆VIM)) maps, respectively, using PHENIX40. Final model evaluations 
were calculated by MolProbity41. Overfitting statistics were calculated by a random 
displacement of atoms in the model followed by a refinement against one of the 
half maps. Finally, Fourier shell correlation (FSC) curves are calculated between 
the volume of the refined model and both half maps using RELION.
Electron-microscopy figure preparation. Figures of electron-microscopy density 
maps and models were visualized and figures were created with UCSF ChimeraX42. 
Electron densities are displayed at multiple contour levels for optimal feature visu-
alization of various components. Contour levels relative to the standard deviation 
(σ) of the corresponding full map values were calculated with UCSF Chimera39. 
For the pre-state map (Fig. 1a), the density of 60S is displayed at 2.1σ, and Vms1, 
Tif6 and tRNA are displayed at 1.33σ. For the post-state map (Fig. 1a), the density 
of both 60S and Tif6 is displayed at 1.69σ, Vms1 LRS–ZnF–VLRF1 is displayed at 
0.76σ, and Vms1 AnkR–CC is displayed at 0.37σ. For the Rqc2 map (EMD-2812, 
Fig. 2e and Extended Data Fig. 3g), the map was first fitted into the grid of the 
pre-state map followed by Gaussian filtration with a width of 1.6. The density of 
P-tRNARqc2 is displayed at 5.16σ, and Rqc2 and A-tRNARqc2 are displayed at 3.45σ. 
For the pre-state map with Arb1 (Fig. 3a), the density of the 60S, Vms1 LRS-VLRF1 
and tRNA is displayed at 1.85σ, Arb1 is displayed at 1.73σ, and Vms1 ZnF–AnkR–
CC and Tif6 are displayed at 0.89σ. Information regarding contour levels for other 
extended data figures is described in the corresponding figure legends.
Statistics and reproducibility. Cryo-EM sample preparation and image data 
collection of Vms1(∆VIM/Q295L) and Vms1(∆VIM) pullouts shown in the 
paper were performed once (n = 1). Preparation of Vms1(∆VIM/Q295L) and 
Vms1(∆VIM) pullouts with or without fixing reagent all showed similar results. 
The quality check of the purified sample (Extended Data Fig. 1a) was performed 
once (n = 1), serving as a confirmation before the cryo-EM analysis. In addition, 
the absence of Cdc48 in Vms1(∆VIM) was reported previously13. In vitro release 
assays in Fig. 2c, d represent two biologically independent repeats (n = 2); release 
assays in Fig. 3f and Extended Data Fig. 3l were both performed once (n = 1), as 
the results were similar in the different strains and they each covered two combi-
nations of protein concentrations. In vivo assays in Figs. 2f, g, 3g–i and Extended 
Data Figs. 2g–j, 3h, m, n represent two biologically independent repeats (n = 2). 
The growth analysis of vms1∆ arb1::degron strain (Extended Data Fig. 3k, left) 
represents two biologically independent repeats (n = 2), and the Arb1 protein 
level (Extended Data Fig. 3k, right) was checked once (n = 1). For all experiments 
with n > 1, representative data from one experiment are shown in the paper. No 
statistical analysis has been applied throughout the work.
Reporting Summary. Further information on research design is available in 
the Nature Research Reporting Summary linked to this paper.
Data availability
The cryo-EM density maps of the pre-state with the absence and presence of Arb1 
and the post-state have been deposited in the Electron Microscopy Data Bank 
under the accession codes EMD-4753, EMD-4751 and EMD-4752. The corre-
sponding atomic models have been deposited in the Protein Data Bank under the 
accession codes 6R87, 6R84 and 6R86. For gel source images, see Supplementary 
Fig. 1.
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Extended Data Fig. 1 | Sample preparation and cryo-EM analysis of 
Vms1–60S ribosomal subunit particles. a, Vms1 and Vms1 mutants 
were immunoprecipitated from the lysates of vms1∆ cells expressing 
Vms1–3C–3×Myc or indicated Vms1 mutants from the GPD1 promoter. 
The precipitates were eluted by 3C cleavage and analysed by SDS–PAGE 
and Coomassie brilliant blue staining. b, Two-dimensional classification 
of Vms1(∆VIM/Q295L)–60S particles (pre-state). c, Two-dimensional 
classification of Vms1(∆VIM)–60S particles (post-state). d, Three-
dimensional classification of Vms1(∆VIM/Q295L)–60S ribosome 
particles (pre-state). Reconstruction in blue and yellow mark final maps. 
e, Three-dimensional classification of Vms1(∆VIM)–60S particles (post-
state). Reconstruction in green marks final map.
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Extended Data Fig. 2 | See next page for caption.
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Extended Data Fig. 2 | Resolution of Vms1 domains and their roles 
in ribosome binding, rescuing growth and preventing mitochondrial 
toxicity. a, Final resolution of Vms1 pre-state and post-state 60S ribosome 
particles. b, Local resolution of Vms1 pre-state and post-state. Left, 
overviews; right, transverse views. The electron density for the pre-state 
is displayed at 1.68σ and for the post-state at 1.83σ. c, Tri-model position 
of Vms1 and its interaction with peptidyl-tRNA (pre-state, top; density 
of Vms1 LRS–VLRF1 and tRNA is displayed at 3.23σ, Vms1 AnkR–CC 
at 2.20σ, nascent chain at 2.10σ, and Vms1 ZnF and Tif6 at 1.29σ) and 
interaction with Tif6 (post-state, bottom; density of Vms1 LRS–ZnF–
VLRF1 and Tif6 is displayed at 2.15σ, and Vms1 AnkR–CC at 0.75σ). Left, 
local resolution; right, density with docked models. d, Fit of models to 
maps. FSC curves calculated between the refined model and the final map 
(black), with the self- and cross-validated correlations in blue and orange, 
respectively. e, Comparison between pre- and post-state of VLRF1 in two 
views (left and middle). Atom-to-atom quantification of the VLRF1 state 
difference (right). f, Prospective transverse model for interaction of the 
Vms1 VIM domain and Cdc48 on the 60S ribosomal subunit.  
g, Vms1 and Vms1 mutants were immunoprecipitated from the lysates of 
vms1∆ cells expressing Vms1–3×Myc or indicated Vms1 mutants from 
the GPD1 promoter. The precipitates were analysed by SDS–PAGE and 
Coomassie brilliant blue staining. Asterisks indicate IgG heavy and light 
chains. h, Rescue of growth of vms1∆ltn1∆ cells by expression of Vms1, 
Vms1(∆ZnF), Vms1(∆AnkR) or Vms1(∆ZnF/∆AnkR) from the VMS1 
promoter. Cells were grown at 37 °C on YPD or YPG plates. i, Prevention 
of aggregation of the NS-mtGFP reporter in vms1∆ cells by overexpression 
of Vms1–3×Myc or indicated Vms1 mutants from the GPD1 promoter. 
The cell extracts were analysed by immunoblotting with the indicated 
antibodies. j, Analysis of the mitochondrial indicator protein Rip1 in 
vms1∆ltn1∆ cells by expression of Vms1–3×Myc or the indicated Vms1 
mutants from the VMS1 promoter. The cells were grown at 30 °C. Cell 
lysates were analysed by immunoblotting using Rip1 and Myc antibodies. 
k, Density and molecular models of Vms1, tRNAVms1, and uL16 loop in 
the pre-state. The density of uL16 is displayed at 4.06σ, tRNA at 3.76σ and 
Vms1 at 3.57σ. See Supplementary Fig. 1 for gel source images.
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Extended Data Fig. 3 | See next page for caption.
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Extended Data Fig. 3 | Interaction of Arb1 with Vms1–60S ribosomal 
subunit complex. a, Final resolution of the Vms1(∆VIM/Q295L) pre-
state in the presence of Arb1. b, Local resolution map of the pre-state 
in the presence of Arb1. Left, overview; right, transverse view. The 
electron density is displayed at 2.21σ. c, Local resolution map of Arb1 
with peptidyl-tRNA. d, Density and docked models of Arb1 and tRNA 
in yellow and blue, respectively. The tRNA density in c, d is displayed at 
3.59σ and the rest remains at 2.21σ. e, View of the Arb1 model surface 
in two orientations. The nucleotide binding domains (NBD1 and 2) and 
the LD are indicated. f, Comparison of Arb1 with ABCF-type ATPases in 
open and closed states. The models of the ADP-bound RLI from P. furiosus 
(PDB 1YQT), the AMP-PNP bound Rli1 from S. cerevisiae (PDB 5LL6) 
and the AMP-PNP bound MsrE from Pseudomonas aeruginosa (PDB 
5ZLU) were compared to Arb1 by rigid-body fitting of NBD1 into the 
density of the Arb1 NBD1. g, Steric clash of Arb1–tRNAVms1 with Rqc2–P-
tRNARqc2 on the 60S subunit. Arb1, tRNAVms1 and Vms1 LRS–VLRF1 
domain are shown as models and Rqc2, A-tRNARqc2 and P-tRNARqc2 
as densities. See Methods for the contour levels. h, Overexpression of 
Arb1–Myc does not lead to displacement of Rqc2 on 60S subunits. Lysates 
of cells expressing Rqc2–3HA from its endogenous promoter with or 
without overexpression of Arb1–1×Myc were analysed by sucrose-
gradient centrifugation. Fractions were analysed by SDS–PAGE and 
immunoblotting using HA and Myc antibodies. 60S and 80S ribosomes 
were detected using anti-Rpl3 antibody. T, top and B, bottom of the 
gradient. i, Density and molecular model of Vms1, tRNAVms1, uL16 and 
Arb1 of the Vms1–60S pre-state in the presence of Arb1. The density of 
25S A2971 is displayed at 5.07σ, Arb1 at 4.55σ, Vms1 at 4.34σ, tRNA at 
3.87σ and uL16 at 3.76σ. j, Model illustrating the rotation of 25S A2971 
(A2602 in E. coli) by 180° upon Arb1 binding. k, The vms1∆ arb1∆ 
shuffle strain was complemented either with an Arb1(WT) construct or 
an Arb1-sAid-HA degron plasmid (Arb1::degron). Growth on YPD and 
YPD + auxin (500 µM final concentration) plates was monitored after two 
days at 30 °C (left). Arb1 protein level of the vms1∆ arb1::degron strain 
before and after treatment with auxin (500 µM final concentration) for 60 
min at 30 °C (right). Cell lysates were analysed by immunoblotting using 
the HA antibody. l, Yeast in vitro release reaction of arrested peptides 
translated from the NS-3×Flag RQC reporter mRNA in vms1∆ski2∆ 
lysate. Buffer (−), Arb1, Vms1 or Vms1 together with Arb1 were added 
to cycloheximide-stopped translation reactions. Incubation time: 5 min 
(lane 1 and 2) at 25 °C; 0, 2 or 5 min, respectively (lanes 3–12). Molar 
ratios of Vms1 and Arb1 are 1 to 25 (Vms1 + Arb1) and 1 to 50 (Vms1 
1/5 + Arb1), respectively. Bottom, longer exposure of the relatively weak 
bands. CCA, CCA from tRNA 3′ end; pep: peptidyl or peptide; * and ** 
indicate peptidyl-tRNA and free peptide from the colliding ribosome, 
respectively. m, Overexpression of Arb1 suppresses aggregation of a NS-
cGFP reporter construct. Cell extracts of ltn1∆ cells expressing NS-cGFP 
and overexpressing Myc-tagged Arb1 or indicated Arb1 mutants were 
analysed by immunoblotting using anti-GFP and anti-Myc antibodies. 
n, Cell lysates of vms1∆arb1∆ cells expressing Arb1–HA or indicated 
Arb1 mutants without or with expression of Vms1–3×Myc were analysed 
by immunoprecipitation using Myc antibody. The inputs and the 
immunoprecipitates were analysed by Coomassie brilliant blue staining 
and immunoblotting using HA antibody. Asterisks indicate IgG heavy 
and light chains. o, Densities and molecular models of Vms1, tRNAVms1 
and uL16 loop in the two pre-states either without Arb1 (left) or with 
Arb1 (middle). Right, the superposition of the uL16 loop in the Arb1 
containing pre-state and in the eIF5A-bound 60S ribosomal subunit (PDB 
5GAK) in purple and pink, respectively. The density of uL16 left structure 
is displayed at 4.06σ; the rest remains the same as in i. p, Model of tRNA 
positioning and dislocation by Arb1. See Supplementary Fig. 1 for gel 
source images.
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Extended Data Fig. 4 | Schematic model of the structural roles of Vms1 
and Arb1 in counteracting CAT-tailing of toxic faulty mitochondrial 
proteins by Rqc2 and promoting their release into the mitochondria. 
Top two rows: in wild-type cells, 60S subunits accumulate in close 
proximity to the protein import complex (TOM) of the outer membrane 
because import can occur co-translationally, especially when translation 
is stalled. Vms1 and Arb1 interfere sterically with binding of Rqc2 on the 
60S subunits and thereby with CAT-tailing, accelerating peptidyl-tRNA 
release. The released polypeptides are imported into the mitochondria 
and degraded by the intramitochondrial chaperone and protease system. 
Middle row: in the absence of Vms1 and Ltn1, CAT-tailed mitochondrial 
proteins are released into the mitochondria where they aggregate with 
pre-existing proteins, leading to breakdown of mitochondrial functions 
in oxidative phosphorylation and other essential processes such as 
mitochondrial protein synthesis. Bottom row: overexpression of Arb1 can 
partially compensate for deficiency of Vms1 and Ltn1 by impairing Rqc2 
dependent CAT-tailing and promoting peptidyl-tRNA release.
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Extended Data Table 1 | Cryo-EM data collection, refinement and validation statistics
Summary of relevant parameters used during cryo-EM data collection and processing. Refinement and validation statistics are provided for the molecular models of the Vms1–60S particles in pre-
state and post-state as well as for the Arb1-containing pre-state particle.
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Extended Data Table 2 | S. cerevisiae strains used in this study
LETTER RESEARCH
Extended Data Table 3 | S. cerevisiae plasmids used in this study
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Source:  
1) Izawa et al. 2017 (home made) 
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Mouse monoclonal anti-GFP antibody 
Source: Roche (Cat.# 11814460001; Lot# 36405300) 
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Source: Sigma-Aldrich (Cat.# A8592) 
 
Rabbit polyclonal anti-Rip1 antibodies 
Source:  
1) Izawa et al. 2017 (home made)  
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3.0.1 VemP, a fresh tip of the iceberg
The ribosomal tunnel provides an approximately 100-Å long environment for newly
synthesized polypeptide chains to pass through. This ribosomal interior provides a
direct ground for specific nascent chains like RAPs to modulate the translation rate,
resulting in immediate and significant downstream consequences for co-translational
protein targeting and folding.
The discovery of the force-sensing VemP has widened the scope of the stalling
modes. The 2.9-Å structure of VemP-mediated ribosome stalling revealed a novel
strategy of arresting a ribosome. When stalled in the ribosome tunnel, it forms an
extensive secondary structure which further extends towards the PTC and disrupts
its catalytic function by steric hindrance. This finding explains why VemP possesses
the longest known arrest stretch to date.
VemP is an elegant modulator that V. alginolyticus employs to switch protein
synthesis between the SecDF1/SecDF2 paralogs, consequently enabling it to adapt
to salinity change in marine-estuarine environment. The switch mechanism de-
pends on the absence or existence of a translocon force, which serves as an indicator
of protein translocation capacity. This mode of regulation can be considered a stress
response to the dysfunction of a protein delivery machine (Ishii et al., 2015).
Thus, one of the next questions is whether more RAPs act in various stressful
conditions such as heat/cold (temperature) shock, changes to salt concentration or
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oxygen level, fluctuation of pH, or viral infection. In the future, we need to integrate
high-throughput screening methods into current biochemical and structural analy-
ses on RAPs. For instance, to detect particular patterns of cis-regulatory events in
open reading frames by comparing the genome-wide ribosome profiles of bacteria
cultured under optimal and stressful conditions.
Although only about 20 RAPs have been discovered so far, it is widely accepted
that cis-acting modulators may be more commonly utilized in translation (Ito and
Chiba, 2013). Previous ribosome profiling experiments have looked for multiple
translation stalling and pause sites in general (Ingolia, Lareau, and Weissman, 2011).
However, studies applying conditional ribosome-profiling to identify novel stalling
sites that are of regulatory importance are lacking.
Moreover, compared to the bacterial RAPs, fewer eukaryotic RAPs have been
characterized; nevertheless, identified eukaryotic RAPs have exhibited distinct bi-
ologic outputs to those in bacteria—for example, repression of metabolite biosyn-
thesis and splicing of the RAP mRNA (Ito and Chiba, 2013). Furthermore, ribosome
profiling on eukaryotic cells has revealed many functionally unassigned uORFs that
may play a regulatory role (Brar and Weissman, 2015). Thus, identifying translated
uORFs in vivo under a condition of interest could be one of the future objectives.
3.0.2 Why does Vms1 cut the tRNA?
The translation machinery may encounter any misprocessed translational compo-
nents that can lead to an aberrantly stalled ribosome with the incompletely synthe-
sized nascent polypeptides. The failure to rescue the ribosome and eliminate the
mRNA and nascent polypeptides in time can be proteotoxic and neurodegenera-
tive disease-related (Choe et al., 2016). The rescue mechanism, the RQC pathway,
undergoes non-canonical nascent chain extension, i.e., CAT-tailing. However, the
puzzle piece of which enzyme is responsible for releasing the nascent chain was
only recently revealed, i.e., Vms1 in yeast (ANKZF1 in human) (Verma et al., 2018;
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Rendón et al., 2018). This finding is vitally crucial since unlimited CAT-tailing of
nuclear-encoded mitochondrial proteins compromises mitochondrial and cellular
homeostasis, whereas Vms1 counteracts CAT-tailing by steric hindrance and pep-
tide release (Izawa et al., 2017).
Surprisingly, despite Vms1 VLRF1 adopting a similar fold and motif to eRF1, it
does not cut the peptidyl-tRNA at the ester bond like what conventional release fac-
tors do. What’s more, the here presented 3.4 Å cryo-electron microscopy structure of
the native Vms1-60S pullout revealed striking remodeling of the tRNA backbone at
the base 73 by Vms1. This position is next to the tRNA CCA-end and thus coincides
nicely with the latest biochemical research clarifying the cutting location, which is
precisely between base 73 and the CCA-end (Yip et al., 2019).
However, why does Vms1 cut the tRNA instead of performing conventional hy-
drolysis of the nascent chain? It is reasonable to hypothesize that RQC might force
the principal translational components’ rechecking by going through the last steps
of component biogenesis. Remarkably, the tRNA cut by Vms1/ANKZF1 produces
a unique 2,3-cyclic phosphate that differentiates from the canonical tRNA substrate
for the addition of the CCA-end. This phosphate must be removed before the rehab
by CCA-adding tRNA biogenesis factor, TRNT1 (Yip et al., 2019).
Interestingly, during the investigation of Vms1, a new RQC player was iden-
tified, which is the previously described ribosome biogenesis factor Argonaute-
binding protein 1 (Arb1). This factor promotes the Vms1 release efficiency by further
stabilizing the Vms1-mediated tRNA backbone remodeling. As Arb1 is an ABCF-
type ATPase, it might also support the disassociation of Vms1 followed by the cut-
ting. Such moonlighting behavior of translational machinery biogenesis factors may
indicate the assumption of rehab checkpoints employed by the RQC pathway, which
needs future investigations.
Another intriguing aspect of the RQC pathway is that it had been thought to be
eukaryotic specific due to a. the existence of the trans-translation system in bacteria
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and b. the principal difference of the input mRNA and the localization of transla-
tion. Surprisingly, recently a similar RQC system was discovered in bacteria (Lytvy-
nenko et al., 2019), where the non-canonical extension to the nascent chain is a CA
tail instead of CAT, presumably due to CAT tails are highly toxic to non-eukaryotic
environments. One of the questions to ask is that why in eukaryotes, such a tail
composition was evolved.
Collectively, a novel mechanistic model of Vms1, Rqc2, and Arb1 activities in
RQC was proposed, in which nucleolytic Vms1 and Arb1 can terminate Rqc2-dependent
CAT-tailing and cooperate in antagonizing CAT-tail-driven mitochondrial toxicity.
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Arb1 Argonaute-Binding protein 1
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B. subtilis Bacillus subtilis
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tRNA transfer RNA
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V. alginolyticus Vibrio alginolyticus





I had an unforgettable adventure through my Ph.D. time. Firstly, I appreciate
Prof. Roland Beckmann accepting me to his lab despite my distinct previous back-
ground (eels vs. ribosomes). His supportive and optimal spirit encouraged me in a
long way.
Secondly, I want to thank Prof. Daniel N. Wilson for the closest collaboration
and all-angle support and Prof. Gunnar von Heijne for the smooth collaboration
and prompt replies. I want to express my most profound respect to Prof. Walter
Neupert and thank him for the lovely experience of working with him. I shall never
forget your spirit towards science, excellence, and responsibilities. Sadly, you left us
before the publication of the Vms1 paper.
Next, I cannot thank enough Dr. Thomas Becker for correcting this dissertation
and kindly providing me a place to sleep in the long winter of 2018 and summer of
2019. Without his support, the revision of the Vms1 paper would not be successful.
Likewise, I want to thank Dr. Toshiaki Izawa and Matthias Thoms for their extreme
excellence in completing the Vms1 story together. I also want to thank Dr. Renuka
Kudva. She is not only a fantastic collaborator but also a good friend willing to sup-
port me anytime. I will never forget the generous help from Dr. Daniel Sohmen, Dr.
Yui Yamashita, Dr. Jacobo Marino, and Dr. Sarah Matheisl in my early times, espe-
cially Dr. Daniel Sohmen, for guiding me through the EM project pipeline. I thank
the "office squad" for the timely help in data processing, including Clara, Andre,
Lukas, and Michi. I cherish my colleagues/friends, like Yui, Jen, Clara, Alex, Jing-
dong, Shuangshuang, Vivek, Anne, Maxi, and Petar, who created the best research
atmosphere and laughter. Moreover, I am grateful to have all of you for discussing
science together, Katharina, Hanna, Tsai, Marko, Lukas, Stephan, and so on.
Furthermore, many thanks to Dr. Otto Berninghausen, Susi Rieder, and Char-
lotte Ungewickell for their dispensable care of the microscopy sample preparation
74
and data collection; to Heidi Sieber, Andera Gilmozzi, Joana Musial for the excel-
lent job they provide to the lab; and to everyone on the 3rd floor of the Gene Center,
especially the ones on the same corridor side of us, for the enjoyable working envi-
ronment.
My experience through the Graduate school of Quantitative Biosciences Mu-
nich (QBM) is precious. QBM offered me cross- and interdisciplinary education
and broadened my perspectives in biophysics and bioinformatics, and allowed me
to attend international conferences, valuable workshops, and enjoyable yearly re-
treats where I earned multiple first awards. I want to give my special thanks to our
beloved QBM speaker Prof. Ulrike Gaul, who sadly left us too soon. You not only
accepted me to the Ph.D. program but also kindly suggested which lab to join. QBM
would look different without you. I also want to thank Dr. Michael Mende and Mara
Kieke for helping me with enormous things when I moved to Munich, and lecturers
Dr. Filiz Civril and Dr. Markus Hohle for giving excellent biochemistry, biophysics,
and bioinformatics courses.
Finally, I appreciate the unconditional love and support in all possible ways from
my parents, grandparents, and my dear husband.
